Pre‐emptive and preventive opioids for postoperative pain in adults undergoing all types of surgery by Doleman, Brett et al.
Cochrane Database of Systematic Reviews
Pre-emptive and preventive opioids for postoperative pain in
adults undergoing all types of surgery (Review)
Doleman B, Leonardi-Bee J, Heinink TP, Bhattacharjee D, Lund JN, Williams JP
Doleman B, Leonardi-Bee J, Heinink TP, Bhattacharjee D, Lund JN, Williams JP.
Pre-emptive and preventive opioids for postoperative pain in adults undergoing all types of surgery.
Cochrane Database of Systematic Reviews 2018, Issue 12. Art. No.: CD012624.
DOI: 10.1002/14651858.CD012624.pub2.
www.cochranelibrary.com
Pre-emptive and preventive opioids for postoperative pain in adults undergoing all types of surgery (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
T A B L E O F C O N T E N T S
1HEADER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2PLAIN LANGUAGE SUMMARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4SUMMARY OF FINDINGS FOR THE MAIN COMPARISON . . . . . . . . . . . . . . . . . . .
6BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
10RESULTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Figure 1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
Figure 2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
Figure 3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
Figure 4. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
Figure 5. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
21ADDITIONAL SUMMARY OF FINDINGS . . . . . . . . . . . . . . . . . . . . . . . . . .
24DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
25AUTHORS’ CONCLUSIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
26ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
26REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
29CHARACTERISTICS OF STUDIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
63DATA AND ANALYSES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Analysis 1.1. Comparison 1 Preventive versus postincision opioids for postoperative pain, Outcome 1 Early acute
postoperative pain (within 6 hours postoperatively). . . . . . . . . . . . . . . . . . . . . . 64
Analysis 1.2. Comparison 1 Preventive versus postincision opioids for postoperative pain, Outcome 2 Nausea and vomiting
(long term). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
Analysis 1.3. Comparison 1 Preventive versus postincision opioids for postoperative pain, Outcome 3 Late acute
postoperative pain (24 to 48 hours postoperatively). . . . . . . . . . . . . . . . . . . . . . 66
Analysis 1.4. Comparison 1 Preventive versus postincision opioids for postoperative pain, Outcome 4 24-hour morphine
consumption (mg). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
Analysis 1.5. Comparison 1 Preventive versus postincision opioids for postoperative pain, Outcome 5 Time to first analgesic
request (minutes). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68
Analysis 1.6. Comparison 1 Preventive versus postincision opioids for postoperative pain, Outcome 6 Pruritus (long
term). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69
Analysis 1.7. Comparison 1 Preventive versus postincision opioids for postoperative pain, Outcome 7 Bradycardia
(incidence). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
Analysis 1.8. Comparison 1 Preventive versus postincision opioids for postoperative pain, Outcome 8 Bradycardia (mean
dose of chronotrope in mcg). . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70
Analysis 1.9. Comparison 1 Preventive versus postincision opioids for postoperative pain, Outcome 9 Hypotension
(incidence). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
71ADDITIONAL TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
73APPENDICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
87CONTRIBUTIONS OF AUTHORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
87DECLARATIONS OF INTEREST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
88DIFFERENCES BETWEEN PROTOCOL AND REVIEW . . . . . . . . . . . . . . . . . . . . .
iPre-emptive and preventive opioids for postoperative pain in adults undergoing all types of surgery (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
[Intervention Review]
Pre-emptive and preventive opioids for postoperative pain in
adults undergoing all types of surgery
Brett Doleman1, Jo Leonardi-Bee2, Thomas P Heinink3 , Debamita Bhattacharjee4, Jon N Lund5 , John P Williams1
1Department of Surgery andAnaesthesia, Division ofMedical Sciences andGraduate EntryMedicine, School ofMedicine, University of
Nottingham,Derby,UK. 2Divisionof Epidemiology andPublicHealth, TheUniversity ofNottingham,Nottingham,UK. 3Department
of Anaesthesia, Frimley Health NHS Foundation Trust, Frimley Park Hospital, Frimley, UK. 4Department of Respiratory Medicine,
Royal Derby Hospital, Derby, UK. 5Division of Health Sciences, School of Medicine, University of Nottingham, Derby, UK
Contact address: Brett Doleman, Department of Surgery and Anaesthesia, Division of Medical Sciences and Graduate Entry Medicine,
School of Medicine, University of Nottingham, Uttoxeter New Road, Derby, DE22 3DT, UK. brett.doleman@nhs.net.
Editorial group: Cochrane Anaesthesia, Critical and Emergency Care Group.
Publication status and date: New, published in Issue 12, 2018.
Citation: Doleman B, Leonardi-Bee J, Heinink TP, Bhattacharjee D, Lund JN, Williams JP. Pre-emptive and preventive opioids
for postoperative pain in adults undergoing all types of surgery. Cochrane Database of Systematic Reviews 2018, Issue 12. Art. No.:
CD012624. DOI: 10.1002/14651858.CD012624.pub2.
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A B S T R A C T
Background
Postoperative pain is a common consequence of surgery and can have deleterious effects. It has been suggested that the administration
of opioid analgesia before a painful stimulus may improve pain control. This can be done in two ways. We defined ’preventive opioids’
as opioids administered before incision and continued postoperatively, and ’pre-emptive opioids’ as opioids given before incision but
not continued postoperatively. Both pre-emptive and preventive analgesia involve the initiation of an analgesic agent prior to surgical
incision with the aim of reducing intraoperative nociception and therefore postoperative pain.
Objectives
To assess the efficacy of preventive and pre-emptive opioids for reducing postoperative pain in adults undergoing all types of surgery.
Search methods
We searched the following electronic databases: CENTRAL, MEDLINE, Embase, AMED, and CINAHL (up to 18 March 2018). In
addition, we searched for unpublished studies in three clinical trial databases, conference proceedings, grey literature databases, and
reference lists of retrieved articles. We did not apply any restrictions on language or date of publication.
Selection criteria
We included parallel-group randomized controlled trials (RCTs) only. We included participants aged over 15 years old undergoing any
type of surgery.We defined postincision opioids as the same intervention administered after incision whether single dose (as comparator
with pre-emptive analgesia) or continued postoperatively (as comparator with preventive analgesia) (control group). We considered
studies that did and did not use a double-dummy placebo (e.g. intervention group received active drug before incision and placebo
after incision; control group received placebo before incision and active drug after incision).
Data collection and analysis
We used the standard methodological procedures expected by Cochrane. Our primary outcomes were: early acute postoperative pain
(measured within six hours and reported on a 0-to-10 scale) and respiratory depression. Our secondary outcomes included: late acute
postoperative pain (24 to 48 hours and reported on a 0-to-10 scale), 24-hour morphine consumption, and adverse events (intraoperative
bradycardia and hypotension). We used GRADE to assess the quality of the evidence for each outcome.
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Main results
We included 20 RCTs, including one unpublished study with 1343 participants. Two studies were awaiting classification as the full
text for these studies was not available. One study evaluated pre-emptive opioids, and 19 studies evaluated preventive opioids. We
considered only one study to be at low risk of bias for most domains. The surgeries and opioids used varied, although roughly half of
the included studies were conducted in abdominal hysterectomy, and around a quarter used morphine as the intervention. All studies
were conducted in secondary care.
Pre-emptive opioids compared to postincision opioids
For pre-emptive opioids in dental surgery, there may be a reduction in early acute postoperative pain (mean difference (MD) -1.20,
95% confidence interval (CI) -1.75 to -0.65; 40 participants; 1 study; low-quality evidence). This study did not report on adverse
events (respiratory depression, bradycardia, or hypotension). There may be a reduction in late acute postoperative pain (MD -2.10,
95% CI -2.57 to -1.63; 40 participants; 1 study; low-quality evidence). This study did not report 24-hour morphine consumption.
Preventive opioids compared to postincision opioids
For preventive opioids, there was probably no reduction in early acute postoperative pain (MD 0.11, 95% CI -0.32 to 0.53; 706
participants; 10 studies; I2 = 61%; moderate-quality evidence). There were no events of respiratory depression in four studies (433
participants). There was no important reduction in late acute postoperative pain (MD -0.06, 95% CI -0.13 to 0.01; 668 participants; 9
studies; I2 = 0%; moderate-quality evidence). There may be a small reduction in 24-hour morphine consumption (MD -4.91 mg, 95%
CI -9.39 mg to -0.44 mg; 526 participants; 11 studies; I2 = 82%; very low-quality evidence). There may be similar rates of bradycardia
(risk ratio (RR) 0.33, 95% CI 0.01 to 7.88; 112 participants; 2 studies; I2 = 0%; low-quality evidence) and hypotension (RR 1.08,
95% CI 0.25 to 4.73; 88 participants; 2 studies; I2 = 0%; low-quality evidence).
Authors’ conclusions
Due to the low quality of the evidence, we are uncertain whether pre-emptive opioids reduce postoperative pain. Based on the trials
conducted thus far, there was no clear evidence that preventive opioids result in reductions in pain scores. It was unclear if there was
a reduction in morphine consumption due to very low-quality of evidence. Too few studies reported adverse events to be able to draw
any definitive conclusions. Once assessed, the two studies awaiting classification may alter the conclusions of the review.
P L A I N L A N G U A G E S U M M A R Y
Pre-emptive and preventive opioids for postoperative pain in adults undergoing all types of surgery
To assess the ability of a single dose of opioid given before making the first cut during surgery (pre-emptive opioids) and preventive
opioids that are given before the first cut and continued after surgery for reducing pain due to surgery in adults.
Review question
We reviewed the evidence for opioid painkillers (strong painkillers) when given before surgery, compared to the same painkiller given
only after the surgeon has cut the skin.
Background
Most people experience pain after surgery that requires strong opioid painkillers. These medications are associated with a number
of side effects including depressed breathing, a slow heart rate, and low blood pressure, as well as vomiting, drowsiness, itching, and
constipation. Reducing the amount of opioid needed can limit these side effects and improve the patient experience. Compared to
starting painkillers later, beginning painkillers before making the first cut for surgery may reduce pain sensitivity, and so lessen the
postoperative pain experienced. We wanted to find out whether giving opioid painkillers before surgery was more effective than giving
the same painkiller after surgery.
Study characteristics
We searched the medical literature for randomized controlled trials (a type of study in which participants are assigned to a treatment
group using a random method) in March 2018. Participants were randomly allocated to one of two groups. One group was treated
with opioids before the surgeon cut the skin, whilst the other group was given the same medication after the surgeon cut the skin. We
identified 20 trials involving a total of 1343 participants aged over 15 years who were undergoing a variety of surgeries. In all but one
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trial, participants received general anaesthetic. Nearly all participants were low-risk patients. Only one of the trials used a pre-emptive
dose of opioid.
Key results
In one small trial (40 participants) involving people undergoing dental surgery, use of pre-emptive opioids resulted in a small reduction
in pain experienced in the first six hours after surgery and at 24 to 48 hours based on low-quality evidence. This study did not report
on adverse events or 24-hour morphine consumption.
For preventive opioids started before the first cut was made and continued over the first day after surgery, pain in the first six hours after
surgery was similar to when the first opioid dose was given after the first cut to the skin (10 studies; 706 participants). Postoperative
pain 24 to 48 hours after surgery was similar between groups (9 studies; 668 participants). The evidence for both these findings was
of moderate quality. The following findings were supported by low- or very low-quality evidence. A reduction in 24-hour morphine
consumption was too small to be clinically relevant (11 studies; 526 participants). Not all studies reported on adverse events, but the
numbers of participants with respiratory depression (4 studies; 433 participants), low heart rate (2 studies; 112 participants), or low
blood pressure (2 studies; 88 participants) were similar between groups.
Quality of the evidence
The quality of the evidence ranged from very low to moderate. The main issues concerning the included trials were high risk of bias
due to limitations in how the findings were presented, the design and conduct of the studies, and wide variations in the findings, which
led to uncertainty in the results. Consequently, we found no convincing evidence that starting opioids before the beginning of surgery
reduces levels of pain after surgery or the need for continuing opioids.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Pre-emptive opioids compared with postincision opioids for postoperative pain
Patient or population: adults undergoing dental surgery
Settings: secondary care in Mexico
Intervention: pre-emptive opioids: opioids init iated before incision but not cont inued postoperat ively
Comparison: post incision opioids: the same analgesic intervent ion init iated af ter surgical incision
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Risk with postincision
opioids
Risk with pre-emptive
opioids
Early acute postoper-
ative pain (measured
within 6 hours postop-
erat ively using a vali-
dated pain scale, 0 no
pain to 10 maximum
pain)
The mean pain was 1.
94 in the post incision
group.
The mean pain was 0.
74 in the pre-emptive
group.
The mean pain was
1.20 (-1.75 to -0.65)
lower.
40
(1 study)
⊕⊕©©
low1
Respiratory depres-
sion (def ined as SaO2 <
92%; yes/ no during the
postoperat ive period)
N/ A N/ A N/ A N/ A N/ A Study did not report this
outcome.
Late acute postopera-
tive pain (measured at
24 to 48 hours postop-
erat ively using a vali-
dated pain scale, 0 no
pain to 10 maximum
pain)
The mean pain was 3.
39 in the post incision
group.
The mean pain was 1.
29 in the pre-emptive
group.
The mean pain was
2.10 (-2.57 to -1.63)
lower.
40
(1 study)
⊕⊕©©
low1
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24-hour morphine con-
sumption (mg) (if al-
ternat ive opioids were
used, we converted
these to morphine
equivalents using stan-
dard conversion fac-
tors)
N/ A N/ A N/ A N/ A N/ A Study did not report this
outcome.
Intraoperative brady-
cardia (yes/ no)
N/ A N/ A N/ A N/ A N/ A Study did not report this
outcome.
Intraoperative
hypotension (yes/ no)
N/ A N/ A N/ A N/ A N/ A Study did not report this
outcome.
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval; N/A: not applicable
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1Downgraded two levels due to concerns over imprecision and risk of bias.
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B A C K G R O U N D
Description of the condition
Postoperative pain is a common consequence of surgery that af-
fects around 80% of patients. The severity of postoperative pain
varies, with 18% of patients suffering extreme pain in one study
(Apfelbaum 2003), and around 25% of participants having se-
vere pain in a more recent study of 22,963 German patients
(Gerbershagen 2014). Pain can have deleterious effects during
the postoperative period, including patient dissatisfaction (Myles
2000), interference with daily activities (Strassels 2002), pul-
monary complications (Desai 1999), increases in the stress re-
sponse to surgery (Desborough 2000), and an increased risk of
chronic postsurgical pain (Kehlet 2006). Risk factors for severe
postoperative pain include the presence of preoperative pain, pre-
operative anxiety, and the type of surgery (Ip 2009). Intravenous
opioids are commonly used to treat pain in the postoperative pe-
riod (Benhamou 2008).However, their use is associatedwithmany
side effects such as vomiting, pruritus (itching), sedation (drowsi-
ness), and patient concerns over addiction (Apfelbaum 2003). Al-
ternative strategies to manage both postoperative pain and reduce
postoperative opioid consumption may therefore have important
benefits for people undergoing surgery.
Description of the intervention
Multimodal or balanced analgesia is the gold standard for peri-
operative pain. However, opioids are still used in the majority of
patients undergoing surgery (Benhamou 2008), despite an asso-
ciation between higher opioid use and lower patient satisfaction
(Mhuircheartaigh 2009). The mechanism of action of opioids in-
volves binding to mu opioid receptors within the central nervous
system, which produces analgesia (Pathan 2012). Although the
efficacy of opioids is well established, recent studies have high-
lighted concerns over the administration of opioids during the pe-
rioperative period (Fletcher 2014). Opioid use is associated with
a range of adverse effects such as hypotension, bradycardia, vom-
iting, constipation, respiratory depression, and suppression of im-
mune function (Wheeler 2002; Williams 2007). Furthermore,
opioid use may be associated with a paradoxical increase in post-
operative pain, a phenomenon known as opioid-induced hyper-
algesia. One meta-analysis found that higher intraoperative doses
of opioids resulted in both higher postoperative pain scores and
opioid consumption (Fletcher 2014).
Pre-emptive analgesia involves the initiation of an analgesic agent
(painkiller) prior to surgical incision (before the surgeon cuts the
skin). It is thought that by initiating analgesic interventions before
surgical injury, the analgesic can provide reductions in intraoper-
ative nociception to the central nervous system and therefore pro-
vide superior pain relief compared with the same analgesic given
postincision (after the surgeon has cut the skin) (Kissin 2000).
Preventive analgesia extends this definition to include increasing
the intensity and duration of pre-emptive analgesic interventions
until final wound healing (Dahl 2011). The first review to examine
the clinical effects of pre-emptive analgesia showed that pre-emp-
tive opioids increased postoperative pain scores when compared to
postincision opioids (Møiniche 2002). A second review published
a few years later also showed a possible increase in postoperative
pain with pre-emptive opioids when compared to postincision
opioids (Ong 2005). However, as these reviews were performed
over a decade ago, new evidence may have changed these conclu-
sions. Furthermore, these reviews did not evaluate reductions in
postoperative opioid side effects and potential adverse events.
How the intervention might work
Surgical incision promotes changes in both the central and pe-
ripheral nervous system known as sensitization. Such sensitization
can cause biochemical changes that manifest as hyperalgesia (the
same pain stimulus causing increased pain) and allodynia (nor-
mally non-painful stimuli causing pain). It is thought that by ini-
tiating analgesia before surgical incision, both peripheral and cen-
tral sensitization can be reduced, resulting in reductions in intra-
operative nociception and later both acute and chronic postoper-
ative pain. Preventive analgesia extends this reduction in sensiti-
zation to include the postoperative period. This enhanced defini-
tion came from an increased understanding of the development
of persistent postsurgical pain, which is associated with postoper-
ative sensitization and may only be reduced by continuing anal-
gesia longer into the postoperative period (Dahl 2011). As opi-
oids are commonly used to treat pain postoperatively (Benhamou
2008), any reductions in opioid use may also result in a reduc-
tion in opioid adverse events and improve the patient experience.
Opioids are known to induce analgesia by binding to mu opioid
receptors within the central nervous system, therefore if these are
initiated before surgical incision, this may reduce sensitization and
thus lead to lower postoperative pain when compared to postin-
cision administration. Conversely, the use of intraoperative opi-
oids has been associated with the phenomenon of opioid-induced
hyperalgesia, which may paradoxically increase postoperative pain
(Fletcher 2014; Ong 2005). Exposure to opioids is thought to in-
crease sensitivity to pain via the glutaminergic system, which may
manifest as increased pain scores following surgery (Lee 2011).
Why it is important to do this review
Due to both its common occurrence and potential deleterious ef-
fects during the postoperative period (Apfelbaum 2003), reduc-
ing postoperative pain is an important clinical issue. A simple ad-
justment in clinical practice, such as changing the timing of ad-
ministration of analgesics, could have important implications for
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postoperative pain management. Moreover, such a change is cost-
neutral and therefore may benefit both anaesthetists in low-in-
come countries and those working within healthcare systems with
finite resources (such as the National Health Service (NHS) in the
UK). A previous review has highlighted an increase in postoper-
ative pain with pre-emptive opioids (Ong 2005), although most
of the data were published over a decade ago, which mandates an
updated review of the evidence.
O B J E C T I V E S
To assess the effects of preventive and pre-emptive opioids for re-
ducing postoperative pain in adults undergoing all types of surgery
(Doleman 2017b).
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included parallel-group randomized controlled trials only. We
also considered studies that did not use a double-dummy placebo
(e.g. intervention group received active drug before incision and
placebo after incision; control group received placebo before in-
cision and active drug after incision). We excluded studies that
included paediatric participants and pharmacokinetic studies not
reporting any clinical outcomes. We excluded no studies on the
basis of language or publication status. We included participants
undergoing general, regional, and local anaesthesia.
Types of participants
We included adults (aged 15 years and older) undergoing any type
of surgery.
We did not include studies that included both participants aged
over 15 years and paediatric participants.
Types of interventions
We compared both preventive opioids and pre-emptive opioids
(intervention groups) with postincision opioids (control group).
We used the following definitions.
1. Preventive opioids: opioids initiated before surgical incision
and continued postoperatively.
2. Pre-emptive opioids: opioids initiated before incision and
not continued postoperatively.
3. Postincision opioids: the same analgesic intervention
initiated after surgical incision, whether single dose (as
comparator with pre-emptive analgesia) or continued
postoperatively (as comparator with preventive analgesia)
(control group).
However, we acknowledged that most studies including opioids
would be preventive by definition (with opioids continued post-
operatively).
We only compared interventions if identical analgesics with iden-
tical dosages were used. In addition, we only included studies if
concurrent use of other multimodal analgesic agents during the
perioperative period was identical to avoid confounding. If the
studies reportedmultiple intervention subgroups that had compa-
rable control groups (identical interventions), we combined these
into one group using methods described in the Cochrane Hand-
book for Systematic Reviews of Interventions (Higgins 2011a). We
included all types of opioid, at any dose, via any route of adminis-
tration (oral and parenteral), and all types of regimen (pre-emptive
or preventive) in the analysis.
Types of outcome measures
Primary outcomes
1. Early acute postoperative pain (measured within six hours
postoperatively using a validated pain scale, converted to a 0-to-
10 scale where a 0-to-100 scale was used; where multiple time
points were reported we included the earliest reported time
point).
2. Respiratory depression (defined as oxygen saturation
(SaO2) < 92%; yes/no).
Secondary outcomes
1. Nausea and vomiting (yes/no).
2. Late acute postoperative pain (measured at 24 to 48 hours
postoperatively using a validated pain scale, converted to a 0-to-
10 scale where a 0-to-100 scale was used; where multiple time
points were reported we included the earliest reported time
point).
3. 24-hour morphine consumption (mg) (if alternative
opioids were used, we converted these to morphine equivalents
using conversion factors) (Table 1) (Doleman 2017a).
4. Time to first analgesic request (minutes).
5. Pruritus (yes/no).
6. Sedation (measured on a continuous scale).
7. Patient satisfaction (converted to a 0-to-10 scale where a 0-
to-100 scale was used).
8. Chronic pain (yes/no, measured three to six months
postoperatively; we included the earliest time point closest to
three months).
9. Time to first bowel movement (hours).
10. Intraoperative bradycardia (yes/no and mean dose of
chronotrope in mg/mcg to assess severity).
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11. Intraoperative hypotension (yes/no and mean dose of
inotrope/vasopressor in mg/mcg to assess severity).
For the secondary outcomes where time points were not specified,
we used the endpoint closest to two hours (one to six hours) to
assess immediate short-term effects, and the endpoint closest to 24
hours (six to 48 hours) to assess longer-term effects.We considered
a reduction in pain score of 1.5 (on a 0-to-10 scale) (Gallagher
2001), a reduction in the time to first analgesic request of one hour,
a time to first bowel movement of 12 hours, a 10 mg reduction
in morphine consumption, and a number needed to treat for an
additional beneficial/harmful outcome (NNTB/NNTH) of 10 as
clinically significant (Doleman 2015a).
Outcomes did not form part of the study eligibility assessment
so studies that met the participant, intervention, and comparison
criteria were included in the review even if they reported no rele-
vant outcomes.
Search methods for identification of studies
Electronic searches
We did not apply any restrictions on the basis of language or
publication status. We translated non-English language studies
where necessary. We searched the following electronic databases
via the Healthcare Databases Advanced Search (HDAS) from the
UK National Institute for Health and Care Excellence: MED-
LINE (1946 to 18 March 2018) (Appendix 1); MEDLINE (In-
Process & Other Non-Indexed Citations); Embase (1974 to 18
March 2018) (Appendix 2); EBSCO Cumulative Index to Nurs-
ing and Allied Health Literature (CINAHL) (1982 to 18 March
2018) (Appendix 2); and theAllied andComplementaryMedicine
Database (AMED) (1985 to 18 March 2018) (Appendix 3). We
also searched the Cochrane Central Register of Controlled Trials
(CENTRAL) (the Cochrane Library, Issue 2, February 2018).
We used the Cochrane Highly Sensitive Search Strategy (sensi-
tivity maximizing version) for identifying randomized controlled
trials in MEDLINE (Lefebvre 2011). We searched the following
databases for unpublished clinical trials:
1. US National Institutes of Health Ongoing Trials Register
ClinicalTrials.gov (www.clinicaltrials.gov);
2. World Health Organization International Clinical Trials
Registry Platform ( apps.who.int/trialsearch/Default.aspx);
3. European Union Clinical Trials Registry (
www.clinicaltrialsregister.eu/).
Searching other resources
We conducted a search of the OpenGrey database to identify grey
literature sources (18 March 2018). We searched reference lists
of identified studies and reviews for further studies. We utilized
Google Scholar to identify studies that have cited the included
studies. In addition, we searched the following conference pro-
ceedings to identify further unpublished studies (all years consid-
ered):
1. World Congress on Pain (International Association for the
Study of Pain);
2. Anaesthetic Research Society Meetings;
3. Association of Anaesthetists of Great Britain and Ireland
Winter Symposium and Annual Congress;
4. American Society of Anesthesiologists Annual Meeting;
5. European Society of Anaesthesiologists Euroanaesthesia
Conference.
Data collection and analysis
Selection of studies
Two review authors (BD and JPW) independently screened the
titles and abstracts of studies identified by the search to determine
their potential relevance based on the inclusion criteria. We re-
trieved the full texts of those studies deemed potentially relevant,
and BD and JPW assessed the full-text articles for eligibility. Any
disagreements were resolved by consensus or by consulting a third
review author (JLB) if necessary. BD and JPW used the informa-
tion from the retrieved reports, such as author name, study cen-
tre, type and dose of interventions used, and study dates, to help
identify any duplicate publications and linked any duplicate pub-
lications.
Data extraction and management
Two review authors (BD and TH) independently extracted data
into an electronic database using standardized data extraction
forms (Appendix 4; Appendix 5), resolving any disagreements by
consensus or by consulting a third review author (DB) if neces-
sary. One review author (BD) performed the analysis. We trans-
lated non-English language studies, and extracted data following
translation. If data were missing from the original research report,
we contacted the corresponding author irrespective of the age of
publication. We extracted the following information:
1. bibliographic data including date of completion/
publication;
2. country;
3. publication status;
4. source of funding;
5. trial design, e.g. parallel;
6. study setting;
7. number of participants randomized to each trial arm and
number included in final analysis;
8. eligibility criteria and key baseline participant data
including sex and age;
9. details of treatment regimen received by each group;
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10. details of any co-interventions;
11. primary and secondary outcome(s) (with definitions and
time points, where applicable);
12. outcome data for primary and secondary outcomes (by
group);
13. duration of follow-up;
14. number of withdrawals (by group) and number of
withdrawals (by group) due to adverse events;
15. adverse events.
Assessment of risk of bias in included studies
We assessed risk of bias in the included studies using the Cochrane
’Risk of bias’ tool (Higgins 2011b). Two review authors (BD and
JPW) independently undertook assessment of risk of bias, and
reached agreement by consensus, consulting a third review author
(JLB) if disagreement persisted.We assessed risk of bias for the do-
mains of sequence generation; allocation concealment; blinding of
participants, study personnel, and outcome assessors; incomplete
outcome data; selective outcome reporting; and other sources of
bias (Appendix 4). We assessed each domain as low, unclear, or
high risk of bias (Higgins 2011b).We presented the results in both
a ’Risk of bias’ summary and a ’Risk of bias’ graph. We interpreted
risk of bias across studies by reducing the quality of evidence if
there was potential risk of bias in the studies included in each
analysis.
Measures of treatment effect
The treatment effects of dichotomous outcomes are presented as
risk ratios (RR) and NNTB/NNTH. We calculated the NNTB/
NNTH from the reciprocal of the risk difference if significant
differences were observed. Continuous outcomes are presented as
mean differences (MD), or if non-comparable scales were used
across studies but still presented as continuous data, as standard-
ized mean differences (SMD). The outcomes of time to first anal-
gesic and time to first bowel movement are presented as hazard
ratios (HR) where reported. We planned to aggregate reported
log hazard ratios, and their associated standard errors, using the
generic inverse variance method, but no studies reported data in
this format. The precision of effect estimates is reported using 95%
confidence intervals (CI).
Unit of analysis issues
As we included parallel-group randomized controlled trials only,
unit of analysis issues were not expected (Higgins 2011c). For the
main results, we combined different subgroups into one treatment
group as suggested in the Cochrane Handbook for Systematic Re-
views of Interventions (Higgins 2011a). When conducting meta-
regression, if a study reported multiple treatment groups for each
covariate, we treated these as separate studies and distributed the
control group participants between the treatment groups to avoid
analysing them twice (Higgins 2011c).
Dealing with missing data
We contacted corresponding authors for any data missing from
the original publication irrespective of publication date. If we re-
ceived no response, we extracted data from published graphs. If
standard deviations were not reported, we attempted to calculate
these from other reported statistics. If this was not possible, we
estimated standard deviations from other studies within the meta-
analysis (Higgins 2011c). We did not attempt to calculate stan-
dard deviations from other measures of dispersion such as the in-
terquartile range.
Assessment of heterogeneity
We assessed clinical heterogeneity by examining study character-
istics such as the type of population, type of surgery, and inter-
vention used, and considered when pooling of results was clini-
cally appropriate. We assessed statistical heterogeneity using the I
2 statistic. We used the following recommended cut-off values in
the interpretation of the I2 statistic (Deeks 2011):
1. 0% to 40% might not be important;
2. 30% to 60% may represent moderate heterogeneity;
3. 50% to 90% may represent substantial heterogeneity;
4. 75% to 100% considerable heterogeneity.
For analyses with substantial or considerable statistical heterogene-
ity, we considered investigating the heterogeneity using meta-re-
gression.
Assessment of reporting biases
We assessed selective outcome reporting by examining the original
study protocol or methods section and comparing these with the
reported results. We reported this as part of the Cochrane ’Risk of
bias’ tool (Higgins 2011b). If 10 or more studies were included in
the meta-analysis, we assessed publication bias graphically using
funnel plots and quantitatively using Egger’s linear regression test
(Egger 1997). Due to the low power of this test, we regarded P <
0.1 as evidence of imprecise study effects and possible publication
bias.
Data synthesis
We used Review Manager 5 to aggregate study data (Review
Manager 2014). We conducted separate analyses for pre-emptive
and preventive interventions. We aggregated data using a DerSi-
monian and Laird random-effects model, as we expected the treat-
ment effect to vary with respect to the different populations within
each study, and therefore there is no single underlying effect to
estimate. For continuous outcomes, we inputted mean, standard
deviation, and sample size data from the individual studies, and
combined these using the generic inverse variance method.Where
raw data could not be extracted from the studies (and the au-
thors did not reply to our request for data), but mean differences
were reported, we would use the generic inverse variance method
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to combine effect measures from studies, although no studies re-
quired this. We combined dichotomous outcomes using theMan-
tel-Haenszel method.
Subgroup analysis and investigation of heterogeneity
We conducted a priori subgroup analysis for the type of opioid
(remifentanil, rapidly short-acting, short-acting, intermediate-act-
ing, and long-acting). We grouped these as follows:
1. rapidly short-acting: alfentanil;
2. short-acting: fentanyl, sufentanil;
3. intermediate-acting: pethidine, morphine;
4. long-acting: tramadol.
If we included 10 or more studies in a meta-analysis, we ex-
plored reasons for heterogeneity by performing a restricted maxi-
mum likelihood, random-effects meta-regression using the covari-
ates type of opioid, dose of opioid (different opioids converted to
morphine equivalents), type of anaesthesia, and type of surgery
(Thompson 2002). For dummy variables, we used the least effec-
tive subgroup as the reference category. We present the R2 ana-
logue with a corresponding P value for each covariate. Due to the
expected low number of studies, we only performed univariate
analysis for each covariate. We used the Knapp-Hartung method
to calculate P values (as this method more appropriately uses the
t distribution for the between-study variance). We performed this
analysis using the software Stata Version 15 (metan and metareg
command).
Sensitivity analysis
We performed sensitivity analysis by restricting the analysis to
studies at low risk of bias (defined as low risk for randomization,
allocation concealment, blinding, and incomplete outcome data,
and not judged as high risk for any other domain). As we judged
studies that did not use a double-dummy design as at high risk
of bias for blinding, we assessed the impact of excluding these
studies from the analysis. We also performed sensitivity analysis
by excluding studies where standard deviations were estimated.
Furthermore, for dichotomous outcomes, if it was unclear if all
randomized participants had been analysed using intention-to-
treat, we assumed that any missing participants did not suffer an
event in the main analysis (best-case scenario). During sensitivity
analysis, we also assumed missing participants did suffer an event
(worst-case scenario). We did not use any other forms of impu-
tation for missing values. For continuous outcomes, we analysed
only the participants whose outcomes were measured (available-
case analysis).
’Summary of findings’ table and GRADE
We have presented outcomes in a ’Summary of findings’ table. We
produced two ’Summary of findings’ tables, one for each compar-
ison:
1. pre-emptive opioids versus postincision opioids (Summary
of findings for the main comparison);
2. preventive opioids versus postincision opioids (Summary of
findings 2).
The outcomes for each comparison included early acute postop-
erative pain, adverse events (respiratory depression, bradycardia,
and hypotension), late acute postoperative pain, and 24-hourmor-
phine consumption. We presented these using the GRADE ap-
proach (Schünemann 2011). We downgraded the quality of ev-
idence from high to moderate, low, or very low. Two review au-
thors (BD and JPW) independently undertook the downgrading
of evidence, reaching agreement by consensus. Characteristics of
the evidence that resulted in downgrading included:
1. limitations in the design and implementation of available
studies suggesting a high likelihood of bias (e.g. studies not using
a double-dummy placebo design);
2. indirectness of evidence (indirect population, intervention,
control, or outcomes);
3. unexplained heterogeneity (I2 > 50%) or inconsistency of
results not explained through meta-regression or sensitivity
analyses;
4. imprecision of results (wide confidence intervals);
5. evidence of publication bias (P < 0.1 on Egger’s linear
regression test).
R E S U L T S
Description of studies
Results of the search
Our search of the electronic databases identified 3728 studies
(Figure 1). We identified no ongoing unpublished studies from
the clinical trial databases or grey literature searching. We identi-
fied two further studies from conference proceedings (Espi 2004;
Kurzova 2005). We found one further study from searching of
reference lists, and those studies that had cited the included stud-
ies. We assessed 23 full-text articles, three of which we excluded.
We excluded one because it did not meet our inclusion crite-
ria, Collis 1995, and two for which only abstracts were avail-
able and there was not enough information to extract data (Espi
2004; Nagasaka 1996). We contacted the authors of 11 studies
(Gerlach 2003; Koprulu 2015; Lenz 2008;Mansfield 1996;Millar
1998; Pozos-Guillen 2007; Sert 2012; Shen 2008; Wilson 1994;
Wordliczek 2002; Zand 2012). We received replies from three of
these (Lenz 2008; Millar 1998; Wilson 1994), but unfortunately
no further data were available. Of the three studies available in ab-
stract form only, we attempted to contact the authors (Espi 2004;
Kurzova 2005;Nagasaka 1996), receiving a response fromonly one
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who provided enough information for inclusion (Kurzova 2005).
Given the possibility of receiving further data in future reviews, we
categorized two of these abstracts to studies awaiting classification
(see Characteristics of studies awaiting classification) (Espi 2004;
Nagasaka 1996).
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Figure 1. Study flow diagram.
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Included studies
Following full-text review, we included 20 studies with a total of
1343 participants.
Participants
The types of surgery conducted in studies were diverse: ab-
dominal hysterectomy in 10 studies (Fassoulaki 1995; Griffin
1997; Kiliçkan 2001; Kurzova 2005; Mansfield 1994; Mansfield
1996;Millar 1998; Richmond 1993; Sarantopoulos 1996;Wilson
1994); dental surgery in two studies (Chew 1997; Pozos-Guillen
2007); lumbar spinal surgery in one study (Gerlach 2003); vari-
cose vein surgery in one study (Koprulu 2015); arthroscopic an-
terior cruciate ligament repair in one study (Lenz 2008); open
cholecystectomy in one study (Pjevic 1999); thyroid and breast
surgery in one study (Sert 2012); lumpectomy in one study (Shen
2008); hemicolectomy in one study (Wordliczek 2002); and open
nephrolithomy inone study (Zand 2012). All studies includedpar-
ticipants undergoing general anaesthesia, except one that was per-
formed under local anaesthesia (Pozos-Guillen 2007). Due to the
nature of the surgery, 10 studies included female participants only
(Fassoulaki 1995; Griffin 1997; Kiliçkan 2001; Kurzova 2005;
Mansfield 1994; Mansfield 1996; Millar 1998; Richmond 1993;
Sarantopoulos 1996; Wilson 1994). Nearly all studies included
low-risk patients (American Society of Anesthesiologists (ASA) 1
or 2), and common exclusion criteria included participants with
systemic disease (especially liver and renal disease) and participants
with chronic pain or chronic use of analgesics and allergies to study
medications.
Settings
All studies were conducted in secondary care (Chew 1997;
Fassoulaki 1995; Gerlach 2003; Griffin 1997; Kiliçkan 2001;
Koprulu 2015; Kurzova 2005; Lenz 2008; Mansfield 1994;
Mansfield 1996; Millar 1998; Pjevic 1999; Pozos-Guillen 2007;
Richmond 1993; Sarantopoulos 1996; Sert 2012; Shen 2008;
Wilson 1994; Wordliczek 2002; Zand 2012). Five studies were
conducted in the UK (Mansfield 1994; Mansfield 1996; Millar
1998; Richmond 1993; Wilson 1994), one in Singapore (Chew
1997), two in Greece (Fassoulaki 1995; Sarantopoulos 1996), one
in Ireland (Griffin 1997), three inTurkey (Kiliçkan 2001; Koprulu
2015; Sert 2012), one in the Czech Republic (Kurzova 2005),
one in Norway (Lenz 2008), one in Croatia (Pjevic 1999), one in
Mexico (Pozos-Guillen 2007), one in China (Shen 2008), one in
Poland (Wordliczek 2002), one in Iran (Zand 2012), and one in
Germany (Gerlach 2003).
Interventions
Opioids studied included: morphine in six studies (Kiliçkan
2001; Kurzova 2005; Mansfield 1996; Millar 1998; Richmond
1993; Zand 2012); tramadol in four studies (Koprulu 2015;
Pozos-Guillen 2007; Shen 2008; Wordliczek 2002); pethidine
in three studies (Chew 1997; Pjevic 1999; Sert 2012); alfen-
tanil in three studies (Griffin 1997; Mansfield 1994; Wilson
1994); fentanyl in one study (Lenz 2008); sufentanil in one
study (Sarantopoulos 1996); fentanyl and sufentanil (different
subgroups within the same study) in one study (Fassoulaki 1995);
and remifentanil in one study (Gerlach 2003). Nearly all studies
evaluated preventive opioids, with only one study evaluating pre-
emptive interventions (Pozos-Guillen 2007).
Comparators
All of the included studies gave identical postincision doses (Chew
1997; Fassoulaki 1995; Gerlach 2003; Griffin 1997; Kiliçkan
2001; Koprulu 2015; Kurzova 2005; Lenz 2008; Mansfield 1994;
Mansfield 1996; Millar 1998; Pjevic 1999; Pozos-Guillen 2007;
Richmond 1993; Sarantopoulos 1996; Sert 2012; Shen 2008;
Wilson 1994; Wordliczek 2002; Zand 2012). Timing of the
postincision dosing varied and included 15 studies that gave the
dose after incision but intraoperatively (Fassoulaki 1995; Gerlach
2003; Griffin 1997; Kiliçkan 2001; Koprulu 2015; Mansfield
1994; Mansfield 1996; Millar 1998; Pjevic 1999; Richmond
1993; Sarantopoulos 1996; Sert 2012; Shen 2008; Wilson 1994;
Zand 2012), and five that gave the dose after surgery (Chew
1997; Kurzova 2005; Lenz 2008; Pozos-Guillen 2007;Wordliczek
2002).
Funding sources
Twelve studies did not report whether or not they received any
funding (Chew 1997; Fassoulaki 1995; Kiliçkan 2001; Mansfield
1994; Mansfield 1996; Millar 1998; Pjevic 1999; Sarantopoulos
1996; Sert 2012; Shen 2008; Wilson 1994; Zand 2012). Five
studies reported receiving funding from non-commercial en-
tities (Gerlach 2003; Griffin 1997; Lenz 2008; Pozos-Guillen
2007;Wordliczek 2002); one study reported receiving no funding
(Koprulu 2015); one study reported receiving funding, although it
was unclear whether this was commercial or not (Kurzova 2005),
and one study author received funding from a commercial entity,
although it was unclear what role the funder had in the study
(Richmond 1993).
Postoperative opioids and concurrent analgesia
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Most of the included studies used patient-controlled analgesia
(PCA) (Gerlach 2003; Griffin 1997; Kiliçkan 2001; Kurzova
2005; Lenz 2008; Mansfield 1994; Mansfield 1996; Millar 1998;
Richmond 1993; Sert 2012; Shen2008;Wilson 1994;Wordliczek
2002; Zand 2012). Postoperative opioids used (on demand) in-
cluded pethidine (Chew 1997; Koprulu 2015; Sarantopoulos
1996), propoxyphene and pethidine (Fassoulaki 1995), pir-
itramide (Gerlach 2003; Pjevic 1999), morphine (Griffin 1997;
Kiliçkan 2001; Kurzova 2005; Mansfield 1994; Mansfield 1996;
Millar 1998; Richmond 1993; Shen 2008; Wilson 1994; Zand
2012), fentanyl and oxycodone (Lenz 2008), and tramadol (Sert
2012; Wordliczek 2002). Concurrent postoperative analgesia in-
cluded paracetamol (Fassoulaki 1995; Koprulu 2015), paraceta-
mol and diclofenac (Lenz 2008), metamizole (Pjevic 1999), dex-
amethasone, paracetamol, and diclofenac (Pozos-Guillen 2007),
propoxyphene and paracetamol (Sarantopoulos 1996), and many
reported no concurrent analgesia or did not mention any in the
methods (Chew1997;Gerlach2003;Griffin1997;Kiliçkan2001;
Kurzova 2005; Mansfield 1994; Mansfield 1996; Millar 1998;
Richmond 1993; Sert 2012; Shen2008;Wilson 1994;Wordliczek
2002; Zand 2012).
Excluded studies
We excluded one study because part of the postincision dosing was
given before incision, therefore it did not satisfy the inclusion crite-
ria as a true postincision intervention (control) (see Characteristics
of excluded studies) (Collis 1995).
Studies awaiting classification
Given the possibility of acquiring further data in future re-
views, we categorized two further studies as awaiting classification
(see Characteristics of studies awaiting classification) (Espi 2004;
Nagasaka 1996). We did not include these studies because they
were only available in abstract format with not enough informa-
tion to extract data, and our attempts to contact the study authors
went unanswered.
Ongoing studies
We did not identify any ongoing studies.
Risk of bias in included studies
We have presented an overview of the risk of bias in the included
studies in Figure 2 and Figure 3.
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Allocation
For random sequence generation, we judged 15 studies as at un-
clear risk of bias as they did not include enough information to
be judged as low risk (Chew 1997; Gerlach 2003; Griffin 1997;
Kiliçkan 2001; Koprulu 2015; Kurzova 2005; Mansfield 1994;
Mansfield 1996; Millar 1998; Pjevic 1999; Pozos-Guillen 2007;
Richmond 1993; Shen 2008; Wilson 1994; Wordliczek 2002).
The remainder of the studies used computer-generated random-
ization and were therefore assessed as at low risk of bias for this
domain (Fassoulaki 1995; Lenz 2008; Sarantopoulos 1996; Sert
2012; Zand 2012). For allocation concealment, 11 studies did
not include enough information to enable a judgement of low
risk and were therefore assessed as at unclear risk of bias (Chew
1997; Gerlach 2003; Koprulu 2015; Kurzova 2005; Mansfield
1994; Pjevic 1999; Pozos-Guillen 2007; Sert 2012; Wilson 1994;
Wordliczek 2002;Zand2012). Three studies used sealed envelopes
with no further details provided and so were judged as at unclear
risk of bias (Fassoulaki 1995; Griffin 1997; Sarantopoulos 1996),
and two studies used sequentially numbered, sealed envelopes that
were either opaque or administered by a third party not involved
in the study, and so were judged as at low risk of bias (Lenz 2008;
Shen 2008). In four studies participants were pharmacy allocated
(Kiliçkan 2001; Mansfield 1996; Millar 1998; Richmond 1993),
therefore these studies were assessed as at low risk of bias for this
domain. No studies were judged as at high risk of bias for either
random sequence generation or allocation concealment.
Blinding
Due to both intervention and control groups receiving an active
intervention, in order for a study to be judged as at low risk of
performance bias it needed to use a double-dummy placebo that
was described as similar or identical in appearance (see Types of
studies). Fourteen studies satisfied the criteria to be judged as at
low risk of bias for this domain (Chew 1997; Fassoulaki 1995;
Griffin 1997; Kiliçkan 2001; Koprulu 2015; Kurzova 2005; Lenz
2008;Mansfield 1996;Millar 1998; Pjevic 1999;Richmond 1993;
Sarantopoulos 1996; Shen 2008; Wilson 1994). Six studies did
not use a double-dummy placebo that was similar in appearance
and were therefore judged as at high risk of performance bias
(Gerlach 2003; Mansfield 1994; Pozos-Guillen 2007; Sert 2012;
Wordliczek 2002; Zand 2012). For detection bias, we assessed
studies as at low risk of bias if they described outcome assessment
as blinded or if it was likely blinded due to masked allocation con-
cealment and identical placebo used. We assessed 14 studies as at
low risk of detection bias (Chew 1997; Fassoulaki 1995; Gerlach
2003; Griffin 1997; Kiliçkan 2001; Kurzova 2005; Lenz 2008;
Mansfield 1994;Mansfield 1996; Richmond 1993; Sarantopoulos
1996; Shen 2008; Wilson 1994; Zand 2012). Four studies in-
cluded insufficient information to be judged as either low or high
risk for this domain (Koprulu 2015; Millar 1998; Pjevic 1999;
Sert 2012). We judged two studies as at high risk of detection
bias, one because no placebo was used (Pozos-Guillen 2007), and
the other because the interventions were administered at different
times (Wordliczek 2002).
Incomplete outcome data
We judged 14 studies as at low risk of attrition bias due to com-
plete follow-up or dropouts that were similar in numbers (Chew
1997; Fassoulaki 1995; Gerlach 2003; Koprulu 2015; Kurzova
2005; Lenz 2008; Mansfield 1994; Mansfield 1996; Pjevic 1999;
Pozos-Guillen 2007; Sarantopoulos 1996; Sert 2012; Shen 2008;
Zand 2012). Three studies did not include enough information to
permit a judgement of low or high risk of bias and were therefore
judged as at unclear risk of bias (Kiliçkan 2001; Wilson 1994;
Wordliczek 2002). We judged three studies as at high risk of attri-
tion bias as participants were excluded for adverse effects that could
have been caused by excess morphine consumption, which intro-
duced bias into the study (Griffin 1997; Millar 1998; Richmond
1993).
Selective reporting
Sixteen studies did not report registration on a clinical trial
database or have a published protocol and so were judged as
at unclear risk of bias for this domain (Chew 1997; Fassoulaki
1995; Gerlach 2003; Griffin 1997; Kiliçkan 2001; Koprulu 2015;
Kurzova 2005; Mansfield 1994; Mansfield 1996; Pjevic 1999;
Richmond 1993; Sarantopoulos 1996; Sert 2012; Shen 2008;
Wilson 1994; Wordliczek 2002). Two studies were registered on
a clinical trial database and reported prespecified outcomes and
so were judged as at low risk of reporting bias (Lenz 2008; Zand
2012). Two studies did not report adverse events that were pre-
specified on a clinical trial registration and therefore were judged
as at high risk of bias for this domain (Millar 1998; Pozos-Guillen
2007).
Other potential sources of bias
We judged all of the included studies as at low risk of other bias as
they had groups with similar baseline characteristics and received
no industry funding, or industry had no clear involvement in
the study (Chew 1997; Fassoulaki 1995; Gerlach 2003; Griffin
1997; Kiliçkan 2001; Koprulu 2015; Kurzova 2005; Lenz 2008;
Mansfield 1994;Mansfield 1996;Millar 1998; Pjevic 1999; Pozos-
Guillen 2007; Richmond 1993; Sarantopoulos 1996; Sert 2012;
Shen 2008; Wilson 1994; Wordliczek 2002; Zand 2012).
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Effects of interventions
See: Summary of findings for themain comparisonPre-emptive
opioids compared with postincision opioids for postoperative
pain; Summary of findings 2 Preventive opioids compared with
postincision opioids for postoperative pain
Pre-emptive opioids versus postincision opioids
Primary outcomes
1. Early acute postoperative pain (measured within six hours
postoperatively)
One study evaluated pre-emptive opioids versus postincision opi-
oids in dental surgery (Pozos-Guillen 2007). There may be a re-
duction in early acute postoperative pain with pre-emptive opioids
(mean difference (MD) -1.20, 95% confidence interval (CI) -1.75
to -0.65; 40 participants; Table 2). We downgraded the quality of
the evidence (by two levels) to low due to concerns over risk of
bias and imprecision.
2. Respiratory depression (defined as SaO2 < 92%; yes/no)
No studies reported respiratory depression for pre-emptive versus
postincision opioids.
Secondary outcomes
1. Nausea and vomiting (yes/no)
No studies reported nausea and vomiting for pre-emptive versus
postincision opioids.
2. Late acute postoperative pain (measured at 24 to 48 hours
postoperatively)
One study evaluated pre-emptive opioids versus postincision opi-
oids in dental surgery (Pozos-Guillen 2007). There may be lower
pain scores in the pre-emptive opioid group (MD -2.10, 95% CI -
2.57 to -1.63; 40 participants; Table 2).We downgraded the qual-
ity of the evidence (by two levels) to low due to concerns over risk
of bias and imprecision.
3. 24-hour morphine consumption (mg)
This outcome does not apply to this comparison, as by definition
pre-emptive opioids were not given during the postoperative pe-
riod.
4. Time to first analgesic request (minutes)
No studies reported time to first analgesic for pre-emptive versus
postincision opioids.
5. Pruritus (yes/no)
No studies reported pruritus for pre-emptive versus postincision
opioids.
6. Sedation (measured on a continuous scale)
No studies reported sedation for pre-emptive versus postincision
opioids.
7. Patient satisfaction (converted to a 0-to-10 scale where a 0-
to-100 scale was used)
No studies reported patient satisfaction for pre-emptive versus
postincision opioids.
8. Chronic pain (yes/no, measured three to six months
postoperatively; we included the earliest time point closest to
three months)
No studies reported chronic pain for pre-emptive opioids versus
postincision opioids.
9. Time to first bowel movement (hours)
No studies reported time to first bowel movement for pre-emptive
versus postincision opioids.
10. Intraoperative bradycardia (yes/no and mean dose of
chronotrope in mg/mcg to assess severity)
No studies reported intraoperative bradycardia or mean dose of
chronotrope for pre-emptive versus postincision opioids.
11. Intraoperative hypotension (yes/no and mean dose of
inotrope/vasopressor in mg/mcg to assess severity)
No studies reported intraoperative hypotension or mean dose of
inotrope for pre-emptive versus postincision opioids.
Preventive opioids versus postincision opioids
Primary outcomes
1. Early acute postoperative pain (measured within six hours
postoperatively)
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Ten studies evaluated preventive opioids versus postincision opi-
oids (Fassoulaki 1995;Gerlach2003;Griffin 1997; Kiliçkan 2001;
Koprulu 2015; Pjevic 1999; Richmond 1993; Sarantopoulos
1996; Shen 2008; Wordliczek 2002). There was probably no im-
portant reduction in early postoperative pain with preventive opi-
oids (MD0.11, 95%CI -0.32 to 0.53; 706 participants; I2 = 61%;
Analysis 1.1). There was no evidence of publication bias on visual
inspection of funnel plots (Figure 4), or Egger’s linear regression
test (P = 0.27). The quality of evidence wasmoderate (downgraded
one level due to concerns over risk of bias). On meta-regression
analysis, type of opioid predicted nearly all of the observed hetero-
geneity (R2 = 98%; P = 0.05; I2 residual = 0%), with longer-acting
opioids the most effective (MD -0.94 for intermediate-acting and
MD -0.55 for long-acting). Type of surgery was not a significant
predictor (R2 = 0%; P = 0.8; I2 residual = 66%). Excluding studies
where standard deviations had been estimated did not change the
results (MD 0.36, 95% CI -0.20 to 0.93).
Figure 4. Funnel plot of comparison: 1 Preventive versus postincision, outcome: 1.1 Early acute
postoperative pain.
The following studies reported continuous outcomes as medians
and were therefore included in a narrative synthesis. Most studies
found no difference in pain scores, although one study did report
lower pain scores in the preventive versus postincision group (2
versus 3, respectively; P = 0.01) (Sert 2012). Of the other stud-
ies reporting similar pain scores, one study reported no difference
recorded at 0.5 hours postoperatively (preventive 2 versus postin-
cision 1; P = 0.17) (Lenz 2008). Another study reported no dif-
ference in pain scores at 2 hours on a 0-to-100-millimetre visual
analogue scale (VAS) (preventive 45.5 mm versus postincision 38
mm; P > 0.05) (Mansfield 1994). A study by the same authors
found no significant difference between preventive and postinci-
sion groups on a 0-to-100-millimetre VAS (48.2 mm versus 58.7
mm, respectively; P > 0.05) (Mansfield 1996). A study conducted
in dental surgery also found no difference at 0.5 hours between
groups (preventive 1.2 versus postincision 1.1; P = 0.9) (Chew
1997). We could not use data from one study because the graphs
contained contradictory legends, although they reported no differ-
ence in the results text (Millar 1998); each graph contained amain
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title of “pain scores at rest” or “pain scores on movement”, whilst
the text underneath the graph explained the opposite condition.
One study reported similar median pain scores in both preventive
and postincision groups (8 versus 8; P = 0.38) (Zand 2012).
2. Respiratory depression (defined as SaO2 < 92%; yes/no)
Four studies (433 participants) reported on respiratory depression
for preventive versus postincision opioids (Griffin 1997; Koprulu
2015; Sert 2012; Shen 2008). However, none of the studies re-
ported any events.
Secondary outcomes
1. Nausea and vomiting (yes/no)
Three studies evaluated long-term outcomes for preventive opi-
oids for the composite outcome of nausea and vomiting (Gerlach
2003; Griffin 1997; Mansfield 1996). Onmeta-analysis there was
probably no difference between groups (risk ratio (RR) 0.90, 95%
CI 0.58 to 1.39; 121 participants; 3 studies; I2 = 0%; Analysis
1.2). The quality of evidence was moderate (downgraded one level
due to concerns over risk of bias). Inputting data assuming that
excluded participants suffered an event did not change the results
for this outcome (RR 0.80, 95% CI 0.54 to 1.18).
2. Late acute postoperative pain (measured at 24 to 48 hours
postoperatively)
Nine studies evaluated late acute postoperative pain for pre-
ventive versus postincision opioids (Fassoulaki 1995; Gerlach
2003; Griffin 1997; Kiliçkan 2001; Koprulu 2015; Pjevic 1999;
Richmond 1993; Sarantopoulos 1996; Shen 2008). On meta-
analysis, we found no difference between groups in pain scores
(MD -0.06, 95% CI -0.13 to 0.01; 668 participants; I2 = 0%;
Analysis 1.3). The quality of evidence was moderate (downgraded
one level due to concerns over risk of bias). Some studies reported
data in graphs that were either bar charts at each time point or line
graphs of pain scores (y axis) and time (x axis). Excluding studies
where standard deviations had been estimated did not change the
results (MD -0.06, 95% CI -0.13 to 0.01).
The following studies reported continuous outcomes as medians
and were therefore included in a narrative synthesis. Studies found
either higher pain scores in the preventive group, Lenz 2008;
Wilson 1994, or similar pain scores (Mansfield 1994; Mansfield
1996; Sert 2012). One study reported higher pain scores on post-
operative day one in the preventive group compared with the
postincision group (2 versus 1; P = 0.02) (Lenz 2008). Another
study also reported higher pain scores in the preventive group at
24 hours on a 0-to-100-millimetre VAS (34 mm versus 23 mm; P
< 0.05) (Wilson 1994). A further study reported no difference in
pain scores at 24 hours using a 0-to-100-millimetre VAS (preven-
tive 28.5 mm versus postincision 21 mm; P > 0.05) (Mansfield
1994). A study by the same authors found no significant differ-
ence on a 0-to-100-millimetre VAS (preventive 23.4 mm versus
postincision 31.5 mm; P > 0.05) (Mansfield 1996). Another study
reported pain scores on a graph, although it was unclear what mea-
sure of central tendency these represented. There was no difference
in pain scores between the preventive and postincision group (0
versus 1, respectively; P > 0.05) (Sert 2012). One study did not re-
port 24-hour pain scores on the graph and so the results could not
be included (Zand 2012). We could not use data from one study
because the graphs contained contradictory legends, although they
reported no difference in the results text (Millar 1998).
3. 24-hour morphine consumption (mg)
Eleven studies evaluated this outcome for preventive versus postin-
cision opioids (Gerlach 2003; Griffin 1997; Kiliçkan 2001;
Koprulu 2015; Kurzova 2005; Lenz 2008; Pjevic 1999; Richmond
1993; Sarantopoulos 1996; Wilson 1994; Zand 2012). However,
in one study no participant received postoperative opioids, thus
this study did not contribute data to the meta-analysis (Pjevic
1999). There may be a small reduction in 24-hour morphine con-
sumption in the preventive group (MD -4.91 mg, 95% CI -9.39
mg to -0.44 mg; 526 participants; I2 = 82%; Analysis 1.4). The
quality of the evidence was very low. There was evidence of pos-
sible publication bias (P = 0.07) (Figure 5). We downgraded the
evidence by three levels due to concerns over risk of bias, possible
publication bias, and unexplained heterogeneity. On meta-regres-
sion analysis for 24-hour morphine consumption, although both
type of opioid (R2 = 45%; P = 0.24; I2 residual = 49%) and type of
surgery (R2 = 42%; P = 0.29; I2 residual = 46%) explained some
of the heterogeneity, neither was statistically significant (P > 0.1).
Excluding studies where standard deviations had been estimated
did not change the results (MD -6.99 mg, 95% CI -14.25 mg to
0.28 mg). When we restricted the analysis to studies at low risk
of bias, only one study remained (Lenz 2008); 24-hour morphine
consumption in this study was similar between groups (MD -1.76
mg, 95% CI -7.64 mg to 4.12 mg). No other results differed from
the main analysis.
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Figure 5. Funnel plot of comparison: 1 Preventive versus postincision, outcome: 1.5 24-hour morphine
consumption (mg).
The following studies reported data as medians and were there-
fore included in a narrative synthesis. None of the studies found
any difference in postoperative opioid consumption (Mansfield
1994; Mansfield 1996; Millar 1998; Shen 2008; Sert 2012). One
study reported similar morphine consumption in the preventive
and postincision group (53.5 mg versus 52 mg, respectively; P >
0.05) (Mansfield 1994). Another study by the same authors found
no difference in morphine consumption, although the difference
included a clinically significant effect (preventive 56 mg versus
postincision 68 mg; P > 0.05) (Mansfield 1996). Another study
reported similar morphine consumption between the preventive
and postincision groups (58 mg versus 57.5 mg, respectively; P >
0.05) (Millar 1998). Similarly, a further study found no difference
in morphine consumption between the preventive and postinci-
sion group (4.6 mg versus 4.1 mg, respectively; P = 0.81) (Shen
2008). One study reported no difference in 24-hour tramadol
consumption between the preventive and postincision group (95
mg versus 86 mg, respectively; P = 0.95) (Sert 2012).
4. Time to first analgesic request (minutes)
No studies reported outcomes as time to event and instead
used continuous scales. Six studies evaluated time to first anal-
gesic request (minutes) for preventive versus postincision opi-
oids (Fassoulaki 1995; Griffin 1997; Koprulu 2015; Pjevic 1999;
Sarantopoulos 1996; Wordliczek 2002). There may be no differ-
ence between groups, and the effect estimate confidence intervals
did not contain our predefined clinically significant threshold of
one hour (MD -8.15 minutes, 95% CI -19.45 minutes to 3.14
minutes; 298 participants; I2 = 63%; Analysis 1.5). The quality of
evidence was low (downgraded two levels due to concerns over risk
of bias and unexplained heterogeneity). Excluding studies where
standard deviations had been estimated did not change the results
(MD -6.52 minutes, 95% CI -20.50 minutes to 7.45 minutes).
Two studies reported outcomes as medians and could not be in-
cluded in the meta-analysis; both studies found no difference be-
tween groups (Chew 1997; Sert 2012). One study reported no dif-
ference in time to first analgesic when reported as median (preven-
tive 279.4 minutes versus postincision 231.6 minutes; P = 0.74)
(Chew 1997). Another study found no difference between the pre-
ventive and postincision groups (45 minutes versus 45 minutes,
respectively; P = 0.8) (Sert 2012).
5. Pruritus (yes/no)
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Three studies evaluated long-term pruritus for preventive versus
postincision opioids (Griffin 1997; Sert 2012; Shen 2008). There
was probably no difference between groups on meta-analysis (RR
0.75, 95% CI 0.40 to 1.43; 383 participants; I2 = 0%; Analysis
1.6). The quality of evidence was moderate (downgraded one level
due to concerns over risk of bias). Inputting data assuming that
excluded participants suffered an event did not change the results
(RR 0.84, 95% CI 0.52 to 1.36).
6. Sedation (measured on a continuous scale)
One study evaluated both short- and long-term sedationmeasured
on a 0-to-100-millimetre VAS (Kiliçkan 2001). There may be no
important difference between groups for either short-term (MD
0.60 mm, 95% CI -2.22 mm to 3.42 mm; 40 participants; Table
3) or long-term sedation (MD 1.40 mm, 95% CI -3.19 mm to
5.99 mm; 40 participants; Table 3). The quality of evidence was
low (downgraded two levels due to concerns over risk of bias and
imprecision).
7. Patient satisfaction (converted to a 0-to-10 scale where a 0-
to-100 scale was used)
One study evaluated long-term patient satisfaction on a 0-to-100-
millimetre VAS (Shen 2008). There was probably no difference
between groups (MD -0.22 mm, 95% CI -0.53 mm to 0.09 mm;
299 participants; Table 3). The quality of evidence was moderate
(downgraded one level due to concerns over risk of bias).
8. Chronic pain (yes/no, measured three to six months
postoperatively; we included the earliest time point closest to
three months)
No studies reported chronic pain for preventive versus postincision
opioids.
9. Time to first bowel movement (hours)
No studies reported time to first bowel movement for preventive
versus postincision opioids.
10. Intraoperative bradycardia (yes/no and mean dose of
chronotrope in mg/mcg to assess severity)
Two studies measured intraoperative bradycardia (incidence) for
preventive versus postincision opioids (Mansfield 1994; Sert
2012). One study reported no events in either group (Sert 2012).
There was only one event in the other study (Mansfield 1994), in
the postincision group (RR 0.33, 95% CI 0.01 to 7.88; 112 par-
ticipants; Analysis 1.7). The quality of evidence was low (down-
graded two levels due to concerns over risk of bias and impreci-
sion). Two studies evaluated mean dose of chronotrope (atropine)
(Mansfield 1994; Sert 2012). No participant required atropine in
one study (Sert 2012). The mean dose of atropine required may
not differ between groups in one study (MD -9.68 mcg, 95% CI -
28.65 mcg to 9.29mcg; 112 participants; Analysis 1.8) (Mansfield
1994). The quality of evidence was low (downgraded two levels
due to concerns over risk of bias and imprecision).
11. Intraoperative hypotension (yes/no and mean dose of
inotrope/vasopressor in mg/mcg to assess severity)
Two studies reported the incidence of intraoperative hypoten-
sion for preventive versus postincision opioids (Griffin 1997; Sert
2012). Theremay be no difference between groups (RR1.08, 95%
CI 0.25 to 4.73; 88 participants; I2 = 0%; Analysis 1.9). The qual-
ity of evidence was low (downgraded two levels due to concerns
over risk of bias and imprecision). One study evaluated the mean
dose of chronotrope/inotrope (ephedrine) (Sert 2012). There was
no difference between groups (MD -0.20 mg, 95% CI -0.59 mg
to 0.19 mg; 50 participants; Table 3). The quality of evidence was
low (downgraded two levels due to concerns over risk of bias and
imprecision). Inputting data assuming that excluded participants
suffered an event did not change the results (RR 0.72, 95% CI
0.24 to 2.13).
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Preventive opioids compared with postincision opioids for postoperative pain
Patient or population: adults undergoing all types of surgery
Settings: secondary care in Greece, Germany, the UK, Ireland, Turkey, Croat ia, Singapore, Poland, China, the Czech Republic, and Iran
Intervention: prevent ive opioids: opioids init iated before surgical incision and cont inued postoperat ively
Comparison: post incision opioids: the same analgesic intervent ion init iated af ter surgical incision
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No. of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Risk with postincision
opioids
Risk with preventive
opioids
Early acute postoper-
ative pain (measured
within 6 hours postop-
erat ively using a vali-
dated pain scale, 0 no
pain to 10 maximum
pain)
The mean pain was 4.
37 (2.94 to 5.79).
The mean pain was 4.
53 (3.13 to 5.93).
The mean pain in the in-
tervent ion groups was
0.11 higher (0.32 lower
to 0.53 higher)
706
(10 studies)
⊕⊕⊕©
moderate1
From studies report-
ing outcomes as medi-
ans, 6 studies reported
no dif ference in pain
scores and 1 reported
lower pain scores in the
prevent ive group
Respiratory depres-
sion (def ined as SaO2 <
92%; yes/ no during the
postoperat ive period)
0 per 1000 0 per 1000 Not est imable 433
(4 studies)
Not est imable No events in any of the
included studies
Late acute postopera-
tive pain (measured at
24 to 48 hours postop-
erat ively using a vali-
dated pain scale, 0 no
pain to 10 maximum
pain)
The main pain was 2.14
(1.36 to 2.92).
The mean pain was 2.
21 (1.39 to 3.03).
The mean pain in the in-
tervent ion groups was
0.06 lower (0.13 lower
to 0.01 higher).
668
(9 studies)
⊕⊕⊕©
moderate1
From studies report-
ing outcomes as medi-
ans, 2 studies reported
higher pain scores in
the prevent ive group
and 3 reported sim i-
lar pain scores between
groups22
P
re
-e
m
p
tiv
e
a
n
d
p
re
v
e
n
tiv
e
o
p
io
id
s
fo
r
p
o
sto
p
e
ra
tiv
e
p
a
in
in
a
d
u
lts
u
n
d
e
rg
o
in
g
a
ll
ty
p
e
s
o
f
su
rg
e
r
y
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
8
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
24-hour morphine con-
sumption (mg) (if al-
ternat ive opioids were
used, we converted
these to morphine
equivalents using stan-
dard conversion fac-
tors)
The mean morphine
consumption was 39.
45 mg (23.75 mg to 55.
14 mg)
The mean morphine
consumption was 34.7
mg (22.37 mg to 47.04
mg)
The mean morphine
consumption in the in-
tervent ion groups was
4.91 mg lower (9.39 mg
lower to 0.44 mg lower)
.
526
(11 studies)
⊕©©©
very low2
Ef fect est imate not clin-
ically signif icant. From
studies report ing out-
comes as medians, no
study found any dif fer-
ence between groups in
morphine consumption
Intraoperative brady-
cardia (yes/ no)
18 per 1000 6 per 1000
(1 to 142)
RR 0.33 (0.01 to 7.88) 112
(2 studies)
⊕⊕©©
low3
Intraoperative
hypotension (yes/ no)
68 per 1000 73 per 1000
(17 to 322)
RR 1.08 (0.25 to 4.73) 88
(2 studies)
⊕⊕©©
low3
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95%CI).
CI: conf idence interval; RR: risk rat io
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
Moderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
1Downgraded one level due to concerns over risk of bias.
2Downgraded three levels due to concerns over risk of bias, possible publicat ion bias, and unexplained heterogeneity.
3Downgraded two levels due to concerns over risk of bias and imprecision.
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D I S C U S S I O N
Summary of main results
There were too few studies to enable us to evaluate the effects of
pre-emptive opioids versus postincision opioids, as only one study
satisfied our inclusion criteria (Pozos-Guillen 2007). In this trial
there may be a reduction in early acute postoperative pain (MD -
1.20, 95% CI -1.75 to -0.65; 40 participants; 1 study; low-quality
evidence). This study did not report adverse events (respiratory
depression, hypotension, or bradycardia). There may also be a
reduction in late acute postoperative pain (MD -2.10, 95% CI -
2.57 to -1.63; 40 participants; 1 study; low-quality evidence). This
study did not report 24-hour morphine consumption. However,
this study was conducted in dental surgery under local anaesthesia.
For preventive versus postincision opioids, there was probably no
difference between groups in early acute postoperative pain (MD
0.11, 95% CI -0.32 to 0.53; 706 participants; 10 studies; I2 =
61%; moderate-quality evidence). There were no events in the
four studies that reported rates of respiratory depression. There
was probably no difference between groups in late acute postop-
erative pain (MD -0.06, 95% CI -0.13 to 0.01; 668 participants;
9 studies; I2 = 0%; moderate-quality evidence). There was a pos-
sible small clinically insignificant reduction in 24-hour morphine
consumption (MD -4.91 mg, 95% CI -9.39 mg to -0.44 mg; 526
participants; 11 studies; I2 = 82%; very low-quality evidence), al-
though this finding was not supported bymost of the other studies
that reported outcome data as medians. There may be no differ-
ence between groups in bradycardia (RR 0.33, 95% CI 0.01 to
7.88; 112 participants; 2 studies; I2 = 0%; low-quality evidence)
and hypotension (RR 1.08, 95% CI 0.25 to 4.73; 88 participants;
2 studies; I2 = 0%; low-quality evidence). The quality of evidence
ranged from moderate to very low, mainly due to concerns over
risk of bias and imprecision related to the low number of included
studies. Consequently, we could find no convincing evidence that
opioids administered before surgical incision improve postopera-
tive pain or opioid adverse events.
Overall completeness and applicability of
evidence
We undertook a wide-ranging search strategy of both published
and unpublished studies. We identified two unpublished studies
from conference proceedings (Espi 2004; Kurzova 2005), and one
study that was unavailable in full text despite our attempts to re-
trieve it from the British Library (Nagasaka 1996). We attempted
to contact the authors of these studies, but received a reply from
only one study author who provided further information that per-
mitted inclusion of the study in the review (Kurzova 2005). Of the
unavailable studies, one study concluded that participants admin-
istered preventive pentazocine had similar analgesic consumption
to those given postincision pentazocine (Nagasaka 1996), and the
other study stated that morphine consumption was higher in the
preventive group, although the difference was not significant (Espi
2004). It is therefore unlikely that the addition of these two stud-
ies would influence the conclusions of the present review. None
of the included studies reported chronic pain, although a lack of
efficacy for acute pain makes reductions in chronic pain unlikely.
Another issue that affected the completeness of our evidence re-
lates to the widespread reporting of central tendency values as me-
dian rather than means. At the protocol stage, we did not plan to
estimate means from medians due to the high likelihood of non-
normal data (Doleman 2017b). Despite this, we found that most
of these studies reported negative results, in keeping with themain
analysis findings, therefore it seems unlikely that this would affect
the conclusions of the review. In addition, no study reported the
outcome of time to first analgesic request as time to event, which
is a more appropriate analysis for this type of outcome. This limits
any conclusions derived from this analysis.
In terms of the applicability of evidence, most studies were
conducted in women undergoing hysterectomy, so it is unclear
whether the results can be extrapolated to other forms of surgery
(Fassoulaki 1995; Griffin 1997; Kiliçkan 2001; Kurzova 2005;
Mansfield 1994; Mansfield 1996; Millar 1998; Richmond 1993;
Sarantopoulos 1996; Wilson 1994). However, a previous review
has shown that type of surgery is not a significant independent
predictor of heterogeneity in meta-analyses of postoperative anal-
gesics (Doleman 2017a). This is also true for the only study that
evaluated pre-emptive interventions (Pozos-Guillen 2007), as this
was conducted in dental surgery under local anaesthetic. It is there-
fore unclear if this evidence can be applied to both more extensive
surgeries where pain levelswould be higher, or surgeries conducted
under general anaesthesia. In addition, all studies were conducted
in low-risk patients, so it unclear whether use in higher-risk pa-
tients may influence outcomes, especially adverse events. Further-
more, many of the studies excluded individuals with chronic pain
and those currently using analgesics, although it is unlikely that
inclusion of such participants would influence the conclusions of
the present review.
Quality of the evidence
The overall quality of the evidence ranged from moderate to very
low, mainly due to concerns over risk of bias and imprecision re-
lated to the low number of included studies for some outcomes.
The quality of the evidence for the main analgesic outcomes of
early and late acute postoperative pain, 24-hour morphine con-
sumption, and time to first analgesic request also ranged from
moderate to very low (mainly secondary to concerns over risk of
bias). However, as the results from our review are negative and
issues with risk of bias are more likely to have exaggerated effect
estimates (Doleman 2017a), higher-quality evidence is unlikely to
alter the conclusions of this review.
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We also found issues of clinical heterogeneity in the included stud-
ies. Firstly, the timing of the pre-emptive/preventive dosing var-
ied in the different studies, with most administering it at induc-
tion. This may have affected the results, as earlier preoperative
dosing may have allowed therapeutic levels to be achieved earlier
before incision and therefore been more effective (especially for
morphine), although dosing closer to incision may be more ap-
propriate for faster-acting opioids (alfentanil). This issue may also
be relevant to postincision dosing. Secondly, the opioids used in
the studies varied, with differing durations of action. Indeed, our
meta-regression analysis suggested that longer-acting opioids may
be more effective in reducing early acute postoperative pain and
could be the focus of future studies. Thirdly, the variation in base-
line pain/opioid consumption may have contributed to clinical
heterogeneity. Studies including participants with higher baseline
pain levels may have shown greater effect sizes, whilst those with
low baseline levels may not have been able to detect a difference
between groups (Doleman 2017a). For example, two studies for
early acute postoperative pain, Pozos-Guillen 2007; Shen 2008,
and seven studies for late acute postoperative pain, Griffin 1997;
Kiliçkan 2001; Koprulu 2015; Pjevic 1999; Richmond 1993;
Sarantopoulos 1996; Shen 2008, included groups with mean pain
scores of three or less, which may limit their ability to detect dif-
ferences between groups.
Potential biases in the review process
None of the review authors were involved in any of the included
studies, making any related bias unlikely. Three review authors
(BD, JPW, and JL) have received funding for an ongoing trial
of preventive paracetamol (not yet unpublished), although this
is unlikely to bias the current review. In terms of the included
studies, many were at unclear or high risk of bias in at least one
domain, which may have introduced bias. This is reflected in the
quality of evidence beingmoderate to very low. The review authors
have recently developed novel methodology for presenting effect
estimates, and are currently developing methods for publication
bias assessment for outcomes such as morphine consumption and
pain scores (which are dependent on baseline risk) (Doleman
2017a). However, although our work indicates bias with the use
of traditional methods, we have used these methods in this review
as they are stipulated by the Cochrane Handbook for Systematic
Reviews of Interventions (Deeks 2011).
Agreements and disagreements with other
studies or reviews
There have been two previous reviews of pre-emptive/preventive
opioids versus postincision opioids (Møiniche 2002; Ong 2005).
One of these reviews included eight studies and found on meta-
analysis that pre-incisional opioids were associated with increases
in postoperative pain (5 mm on a 0-to-100-millimetre VAS, 95%
CI 1 mm to 9 mm), although analgesic consumption was reduced
in two trials, similar to our findings (Møiniche 2002). These results
contrast with the results of our review, where we found no differ-
ence between groups in pain scores. The other review found that
pre-incisional opioids increased pain scores (standardised mean
difference (SMD) 0.24, 95% CI 0.46 to 0.01), but there was no
difference in analgesic consumption (SMD -0.23, 95% CI 0.06 to
-0.52) (Ong 2005). Again, we found no difference in pain scores.
It is important to note that our review includes many studies that
have been published since these previous reviews were undertaken.
Based on both our results and those from these previous reviews,
it appears that preventive opioids are not efficacious in reducing
pain scores following surgery.
In comparison with other analgesics used around the periopera-
tive period (Doleman 2017a), the 24-hour morphine reductions
observed in this review are similar to lidocaine (5 mg) and dex-
amethasone (4 mg) but less effective than gabapentinoids (8 mg),
paracetamol (8 mg), alpha-2 agonists (11 mg), and non-steroidal
anti-inflammatory drugs (11 mg). However, these comparisons do
not take into account variable baseline risk and should be inter-
preted with caution (Doleman 2017a).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
We found no evidence from the trials conducted thus far that pre-
ventive opioids result in clinically significant reductions in pain
scores, morphine consumption, or time to first analgesic request.
Furthermore, there were probably little or no differences in post-
operative opioid complications.Datawere insufficient to draw any
conclusions regarding adverse events. We included only one study
evaluating pre-emptive opioids, which was conducted in dental
surgery, limiting any conclusions on this analgesic strategy. The
two studies awaiting classification may alter the conclusions of
the review once assessed (see Characteristics of studies awaiting
classification). The results of this review indicate that the current
practice of using long-acting opioids as pre-medication may not
have a strong evidence base. There may not be any clinically signif-
icant effect in reducing pain or opioid consumption after surgery.
In addition, too few studies assessed adverse events such as brady-
cardia and hypotension, which may be affected by preoperative
administration, to permit any conclusions. Such intraoperative
haemodynamic effects may be associated with significant adverse
events such as stroke (Bijker 2012). Conversely, preoperative opi-
oids may reduce haemodynamic responses to intubation, which
may benefit high-risk patients (Doleman 2016).
Implications for research
If further studies are to be undertaken despite a lack of efficacy
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shown in this review, theywould need to use methodology that en-
sures adequate randomization, allocation concealment, and blind-
ing to improve the quality of evidence (Doleman 2017a). In addi-
tion, future studies may wish to focus on analgesics with a longer
duration of action as indicated on meta-regression analysis, al-
though the inherent limitations of these analyses and small sample
sizes limit any conclusions. Finally, if future studies are performed,
they may wish to be conducted in surgeries with higher postoper-
ative morphine consumption to improve absolute benefits, if ben-
efits exist (Doleman 2017a).
A C K N OW L E D G E M E N T S
We would like to acknowledge the editorial comments of Mari-
alenaTrivella, AnnaLee, ArashAfshari, BronaghBlackwood,Asieh
Golozar, Nathan Pace, Jane Cracknell, and Nuala Livingstone (ed-
itorial screening of protocol) (Doleman 2017b).
Wewould also like to thankMike Bennett (Content Editor), Asieh
Golozar (Statistical Editor), Andrew Smith (Co-ordinating Edi-
tor), Liz Bickerdike (Cochrane Editorial Unit), and David Dick-
erson and R Andrew Moore (Peer Referees) for their help and edi-
torial advice during the preparation of the protocol for the system-
atic review (Doleman 2017b). In addition, we would like to thank
Michael Bennett (Content Editor), VibekeHorstmann (Statistical
Editor), David Dickerson, Jean-Pierre C Estebe, Ole Mathiesen
(Peer Reviewers), and JanetWale (Consumer Editor) for their help
and editorial advice during the preparation of this systematic re-
view.
R E F E R E N C E S
References to studies included in this review
Chew 1997 {published data only}
Chew ST, Low TC. Preoperative versus postoperative
pethidine for extraction of impacted third molars. Annals
of the Academy of Medicine, Singapore 1997;26(4):426–9.
PUBMED: 9395803]
Fassoulaki 1995 {published data only}
Fassoulaki A, Sarantopoulos C, Zotou M, Papoulia D.
Preemptive opioid analgesia does not influence pain after
abdominal hysterectomy. Canadian Journal of Anaesthesia
1995;42(2):109–13. PUBMED: 7720151]
Gerlach 2003 {published data only (unpublished sought but not used)}
Gerlach K, Uhlig T, Hppe M, Khirt T, Saager L, Schmucker
P. Postoperative analgesia after preincisional administration
of remifentanil. Minerva Anestesiologica 2003;69(6):563–9.
PUBMED: 14564253]
Griffin 1997 {published data only}
Griffin MJ, Hughes D, Knaggs A, Donnelly MB, Boylan
JF. Late-onset preemptive analgesia associated with
preincisional large-dose alfentanil. Anesthesia and Analgesia
1997;85(6):1317–21. PUBMED: 9390601]
Kiliçkan 2001 {published data only}
Kiliçkan L, Toker K. The effect of preemptive intravenous
morphine on postoperative analgesia and surgical stress
response. Revista Brasileira de Anestesiologia 2001;51(6):
503–10. DOI: 10.1590/S0034-70942001000600005
Koprulu 2015 {published data only (unpublished sought but not used)}
Köprülü AS, Sener T, Gül YG, Haspolat A, Neymen
B. Comparison between the effects of preoperative
(preemptive) and intraoperative use of tramadol on post-
operative pain. Haseki Tip Bulteni 2015;53(3):220–4.
DOI: 10.4274/haseki.2389
Kurzova 2005 {unpublished data only}
Kurzova A, Malek J, Noskova P, Bendova M, Strunova M.
Pre-emptive analgesia with combination of morphine and
ketamine: A-724. European Journal of Anaesthesiology 2005;
22:187 [unpublished].
Lenz 2008 {published data only (unpublished sought but not used)}
Lenz H, Raeder J, Hoymork SC. Administration of
fentanyl before remifentanil-based anaesthesia has no
influence on post-operative pain or analgesic consumption.
Acta Anaesthesiologica Scandinavica 2008;52(1):149–54.
PUBMED: 17996006]
Mansfield 1994 {published data only}
Mansfield M, Meikle R, Miller C. A trial of pre-emptive
analgesia. Influence of timing of peroperative alfentanil on
postoperative pain and analgesic requirements. Anaesthesia
1994;49(12):1091–3. PUBMED: 7864328]
Mansfield 1996 {published data only (unpublished sought but not
used)}
Mansfield MD, James KS, Kinsella J. Influence of dose and
timing of administration of morphine on postoperative pain
and analgesic requirements. British Journal of Anaesthesia
1996;76(3):358–61. PUBMED: 8785133]
Millar 1998 {published data only (unpublished sought but not used)}
Millar AY, Mansfield MD, Kinsella J. Influence of timing
of morphine administration on postoperative pain and
analgesic consumption. British Journal of Anaesthesia 1998;
81(3):373–6. PUBMED: 9861123]
Pjevic 1999 {published data only}
Pjevi M, Komarcevi M, Kovacevi S, Jovanovi L, Gaji
S. Preemptive analgesia in cholecystectomy using
pethidine. Medicinski Pregled 1999;52(11-12):485–8.
PUBMED: 10748772]
26Pre-emptive and preventive opioids for postoperative pain in adults undergoing all types of surgery (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Pozos-Guillen 2007 {published data only (unpublished sought but not
used)}
Pozos-Guillen A, Martinez-Rider R, Aguirre-Banuelos P,
Perez-Urizar J. Pre-emptive analgesic effect of tramadol after
mandibular third molar extraction: a pilot study. Journal
of Oral and Maxillofacial Surgery 2007;65(7):1315–20.
PUBMED: 17577495]
Richmond 1993 {published data only}
Richmond CE, Bromley LM, Woolf CJ. Preoperative
morphine pre-empts postoperative pain. Lancet 1993;342
(8863):73–5. PUBMED: 8100911]
Sarantopoulos 1996 {published data only}
Sarantopoulos C, Fassoulaki A. Sufentanil does not preempt
pain after abdominal hysterectomy. Pain 1996;65(2-3):
273–6. PUBMED: 8826517]
Sert 2012 {published data only (unpublished sought but not used)}
Sert H, Dem rc o lu R , Usta B, Muslu B, Yazici Ü,
Gözdem r M, et al. A comparative study of preoperative
versus intraoperative meperidine administration in patients
receiving general anesthesia: a prospective, randomized
double-blind study. Turkish Journal of Medical Sciences
2012;42(1):47–54. DOI: 10.3906/sag-1010-1226
Shen 2008 {published data only (unpublished sought but not used)}
Shen X, Wang F, Xu S, Ma L, Liu Y, Feng S, et al.
Comparison of the analgesic efficacy of preemptive and
preventive tramadol after lumpectomy. Pharmacological
Reports 2008;60(3):415–21. PUBMED: 18622068]
Wilson 1994 {published data only (unpublished sought but not used)}
Wilson RJ, Leith S, Jackson IJ, Hunter D. Pre-emptive
analgesia from intravenous administration of opioids. No
effect with alfentanil. Anaesthesia 1994;49(7):591–3.
PUBMED: 8042723]
Wordliczek 2002 {published data only (unpublished sought but not
used)}
Wordliczek J, Banach M, Garlicki J, Jakowicka-Wordliczek
J, Dobrogowski J. Influence of pre- or intraoperational use of
tramadol (preemptive or preventive analgesia) on tramadol
requirement in the early postoperative period. Polish Journal
of Pharmacology 2002;54(6):693–7. PUBMED: 12866726]
Zand 2012 {published data only (unpublished sought but not used)}
Zand F, Amini A, Hamidi SA. Effect of timing of morphine
administration during propofol-remifentanil anesthesia on
the requirements of post-operative analgesia. Korean Journal
of Anesthesiology 2012;63(3):233–7. PUBMED: 23060980]
References to studies excluded from this review
Collis 1995 {published data only}
Collis R, Brandner B, Bromley LM, Woolf CJ. Is there any
clinical advantage of increasing the pre-emptive dose of
morphine or combining pre-incisional with postoperative
morphine administration?. British Journal of Anaesthesia
1995;74(4):396–9. PUBMED: 7734257]
References to studies awaiting assessment
Espi 2004 {unpublished data only}
Espí C, Vila P, Muñoz S, Monerris M, Lopez M, Canet
J. Morphine requirements during early recovery from
remifentanil-based anaesthesia for gynecological surgery:
A-770. European Journal of Anaesthesiology 2004;21:189.
DOI: 10.1097/00003643-200406002-00687
Nagasaka 1996 {published data only}
Nagasaka H, Taguchi M, Mizumoto Y, Hori K, Hayashi
K, Sugai M, et al. Pre-emptive analgesia from intravenous
administration of opioid: no effect with pentazocine.
Masui. The Japanese Journal of Anesthesiology 1996;45(6):
750–5. PUBMED: 8752779]
Additional references
Apfelbaum 2003
Apfelbaum JL, Chen C, Mehta SS, Gan TJ. Postoperative
pain experience: results from a national survey suggest
postoperative pain continues to be undermanaged.
Anesthesia and Analgesia 2003;97(2):534–40. [PUBMED:
12873949]
Benhamou 2008
Benhamou D, Berti M, Brodner G, Andres JD, Draisci G,
Moreno-Azcoita M, et al. Postoperative Analgesic THerapy
Observational Survey (PATHOS): a practice pattern study
in 7 central/southern European countries. Pain 2008;136
(1-2):134–41. [PUBMED: 17703887 ]
Bijker 2012
Bijker JB, Persoon S, Peelen LM, Moons KG, Kalkman
CJ, Kappelle LJ, et al. Intraoperative hypotension and
perioperative ischemic stroke after general surgery: a nested
case-control study. Anesthesiology 2012;116(3):658–64.
[PUBMED: 22277949]
Dahl 2011
Dahl JB, Kehlet H. Preventive analgesia. Current Opinion in
Anaesthesiology 2011;24(3):331–8. [PUBMED: 21478742]
Deeks 2011
Deeks JJ, Higgins JP, Altman DG. Chapter 9: Analysing
data and undertaking meta-analyses. In: Higgins JP,
Green S (editors). Cochrane Handbook for Systematic
Reviews of Interventions Version 5.1.0 (updated March
2011). The Cochrane Collaboration, 2011. Available from
handbook.cochrane.org.
Desai 1999
Desai PM. Pain management and pulmonary dysfunction.
Critical Care Clinics 1999;15(1):151–66. [PUBMED:
9929792]
Desborough 2000
Desborough JP. The stress response to trauma and
surgery. British Journal of Anaesthesia 2000;85(1):109–17.
[PUBMED: 10927999]
Doleman 2015a
Doleman B, Heinink TP, Read DJ, Faleiro RJ, Lund JN,
Williams JP. A systematic review and meta-regression
analysis of prophylactic gabapentin for postoperative
pain. Anaesthesia 2015;70(10):1186–204. [PUBMED:
26300519]
27Pre-emptive and preventive opioids for postoperative pain in adults undergoing all types of surgery (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Doleman 2015b
Doleman B, Read D, Lund JN, Williams JP. Preventive
acetaminophen reduces postoperative opioid consumption,
vomiting, and pain scores after surgery: systematic review
and meta-analysis. Regional Anesthesia and Pain Medicine
2015;40(6):706–12. [PUBMED: 26469366]
Doleman 2016
Doleman B, Sherwin M, Lund JN, Williams JP. Gabapentin
for the hemodynamic response to intubation: systematic
review and meta-analysis. Canadian Journal of Anesthesia
2016;63(9):1042–58. [PUBMED: 27206565]
Doleman 2017a
Doleman B, Sutton AJ, Sherwin M, Lund JN, Williams
JP. Baseline morphine consumption may explain between-
study heterogeneity in meta-analyses of adjuvant analgesics
and improve precision and accuracy of effect estimates.
Anesthesia and Analgesia 2017;126(2):648–60. [PUBMED:
28682950]
Egger 1997
Egger M, Smith GD, Schneider M, Minder C. Bias in
meta-analysis detected by a simple, graphical test. BMJ
1997;315(7109):629–34. [PUBMED: 9310563]
Fletcher 2014
Fletcher D, Martinez V. Opioid-induced hyperalgesia in
patients after surgery: a systematic review and a meta-
analysis. British Journal of Anaesthesia 2014;112(6):
991–1004. [PUBMED: 24829420]
Gallagher 2001
Gallagher EJ, Liebman M, Bijur PE. Prospective validation
of clinically important changes in pain severity measured on
a visual analog scale. Annals of Emergency Medicine 2001;38
(6):633–8. [PUBMED: 11719741]
Gerbershagen 2014
Gerbershagen HJ, Pogatzki-Zahn E, Aduckathil S, Peelen
LM, Kappen TH, van Wijck AJ, et al. Procedure-
specific risk factor analysis for the development of severe
postoperative pain. Anesthesiology 2014;120(5):1237–45.
[PUBMED: 24356102]
Higgins 2011a
Higgins JP, Deeks JJ. Chapter 7: Selecting studies and
collecting data. In: Higgins JP, Green S editor(s). Cochrane
Handbook for Systematic Reviews of Interventions Version
5.1.0 (updated March 2011). The Cochrane Collaboration,
2011. Available from handbook.cochrane.org.
Higgins 2011b
Higgins JP, Altman DG, Sterne JAC. Chapter 8: Assessing
risk of bias in included studies. In: Higgins JP, Green S
editor(s). Cochrane Handbook for Systematic Reviews
of Interventions Version 5.1.0 (updated March 2011).
The Cochrane Collaboration, 2011. Available from
handbook.cochrane.org.
Higgins 2011c
Higgins JP, Deeks JJ, Altman DG. Chapter 16: Special
topics in statistics. In: Higgins JP, Green S editor
(s). Cochrane Handbook for Systematic Reviews of
Interventions Version 5.1.0 (updated March 2011).
The Cochrane Collaboration, 2011. Available from
handbook.cochrane.org.
Ip 2009
Ip HYV, Abrishami A, Peng PW, Wong J, Chung F.
Predictors of postoperative pain and analgesic consumption:
a qualitative systematic review. Anesthesiology 2009;111(3):
657–77. [PUBMED: 19672167]
Kehlet 2006
Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical
pain: risk factors and prevention. Lancet 2006;367(9522):
1618–25. [PUBMED: 16698416]
Kissin 2000
Kissin I. Preemptive analgesia. Anesthesiology 2000;93(4):
1138–43. [PUBMED: 11020772]
Lee 2011
Lee M, Silverman S, Hansen H, Patel V, Manchikanti L. A
comprehensive review of opioid-induced hyperalgesia. Pain
Physician 2011;14(2):145–61. [PUBMED: 21412369]
Lefebvre 2011
Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching
for studies. In: Higgins JP, Green S editor(s). Cochrane
Handbook for Systematic Reviews of Interventions Version
5.1.0 (updated March 2011). The Cochrane Collaboration,
2011. Available from handbook.cochrane.org.
Mhuircheartaigh 2009
Mhuircheartaigh RN, Moore RA, McQuay HJ. Analysis
of individual patient data from clinical trials: epidural
morphine for postoperative pain. British Journal of
Anaesthesia 2009;103(6):874–81. [PUBMED: 19889750]
Myles 2000
Myles PS, Williams DL, Hendrata M, Anderson H, Weeks
AM. Patient satisfaction after anaesthesia and surgery:
results of a prospective survey of 10,811 patients. British
Journal of Anaesthesia 2000;84(1):6–10. [PUBMED:
10740539]
Møiniche 2002
Møiniche S, Kehlet H, Dahl JB. A qualitative and
quantitative systematic review of preemptive analgesia for
postoperative pain relief: the role of timing of analgesia.
Anesthesiology 2002;96(3):725–41. [PUBMED: 11873051]
Ong 2005
Ong CKS, Lirk P, Seymour RA, Jenkins BJ. The efficacy
of preemptive analgesia for acute postoperative pain
management: a meta-analysis. Anesthesia and Analgesia
2005;100(3):757–73. [PUBMED: 15728066]
Pathan 2012
Pathan H, Williams J. Basic opioid pharmacology:
an update. British Journal of Pain 2012;6(1):11–6.
[PUBMED: 26516461]
Review Manager 2014 [Computer program]
Nordic Cochrane Centre, The Cochrane Collaboration.
Review Manager 5 (RevMan 5). Version 5.3. Copenhagen:
Nordic Cochrane Centre, The Cochrane Collaboration,
2014.
28Pre-emptive and preventive opioids for postoperative pain in adults undergoing all types of surgery (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Schünemann 2011
Schünemann HJ, Oxman AD, Vist GE, Higgins JP,
Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting
results and drawing conclusions. In: Higgins JP, Green
S (editors). Cochrane Handbook for Systematic Reviews
of Interventions Version 5.1.0 (updated March 2011).
The Cochrane Collaboration, 2011. Available from
handbook.cochrane.org.
Stata Version 15 [Computer program]
StataCorp. Stata Statistical Software: Release 15. Version
Accessed June 2017. College Station, TX: StataCorp LLC,
2017.
Strassels 2002
Strassels SA, Chen C, Carr DB. Postoperative analgesia:
economics, resource use, and patient satisfaction in an
urban teaching hospital. Anesthesia and Analgesia 2002;94
(1):130–7. [PUBMED: 11772815]
Thompson 2002
Thompson SG, Higgins JP. How should meta-regression
analyses be undertaken and interpreted?. Statistics in
Medicine 2002;21(11):1559–73. [PUBMED: 12111920]
Wheeler 2002
Wheeler M, Oderda GM, Ashburn MA, Lipman AG.
Adverse events associated with postoperative opioid
analgesia: a systematic review. Journal of Pain 2002;3(3):
159–80. [PUBMED: 14622770]
Williams 2007
Williams JP, Thompson JP, McDonald J, Barnes TA,
Cote T, Rowbotham DJ, et al. Human peripheral blood
mononuclear cells express nociceptin/orphanin FQ, but not
µ, δ, or κ opioid receptors. Anesthesia and Analgesia 2007;
105(4):998–1005. [PUBMED: 17898379]
References to other published versions of this review
Doleman 2017b
Doleman B, Leonardi-Bee J, Heinink TP, Lund J, Williams
JP. Preventive opioids for postoperative pain. Cochrane
Database of Systematic Reviews 2017, Issue 4. DOI:
10.1002/14651858.CD012624
∗ Indicates the major publication for the study
29Pre-emptive and preventive opioids for postoperative pain in adults undergoing all types of surgery (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Chew 1997
Methods Study design: parallel-group randomized controlled trial
Sample size: 40
Country: Singapore
Setting: secondary care hospital
Dates conducted: not reported
Postoperative opioid used and delivery: pethidine 50 mg intramuscularly if VAS > 50
mm
Pain score collection: recorded by blinded nursing staff
Concurrent postoperative analgesics: none reported
Participants Inclusion criteria
1. ASA 1 only
2. No systemic disease
3. Undergoing removal of bilateral impacted third molars under general anaesthesia
Exclusion criteria
1. Known allergy to opioids
2. Systemic illnesses
Interventions Group 1 (20 participants): intramuscular pethidine 50 mg 1 to 2 hours before surgery
and 1 mL saline placebo immediately after surgery
Group 2 (20 participants): 1 mL saline placebo 1 to 2 hours before surgery and intra-
muscular pethidine 50 mg immediately after surgery
Outcomes 1. Postoperative pain (0-to-100-millimetre VAS at 30 minutes, 1, 3, and 6 hours)
2. Pethidine consumption (mg, time point not reported)
Notes Funding: none reported
Declarations of interest: none declared
Authors contacted: no
Other: postoperative pain reported asmedian so included innarrative synthesis. Pethidine
consumption not included, as time point not reported and study follow-up only 6 hours
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details. Quote: “participants were allo-
cated randomly to two groups”
Allocation concealment (selection bias) Unclear risk Not mentioned
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Double-dummy placebo of saline intra-
muscularly and described as identical.
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Chew 1997 (Continued)
Quote: “during the study, each patient re-
ceived two identical, coded 1ml injections;
one containing pethidine 50 mg, the other
containing normal saline”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Blinded. Quote:
“these values were recorded by the nursing
staff who were unaware of the sequence of
administration of the injections”
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants analysed, and numbers in
table match the number randomized
Selective reporting (reporting bias) Unclear risk No protocol or trial registration
Other bias Low risk Similar baseline characteristics. No indus-
try funding reported
Fassoulaki 1995
Methods Study design: parallel-group randomized controlled trial
Sample size: 85
Country: Greece
Setting: secondary care hospital
Dates conducted: not reported
Postoperative opioid used and delivery: (see below)
Pain score collection: collected by independent observer
Concurrent postoperative analgesics: propoxyphene 75 mg with paracetamol 1600 mg
intramuscularly 6 hourly supplemented by meperidine 50 mg given intramuscularly 12
hours postoperatively
Participants Inclusion criteria
1. Female participants
2. ASA 1 and 2
3. Scheduled for elective abdominal hysterectomy via a midline subumbilical incision
Exclusion criteria
1. History of chronic pain
2. Regular intake of analgesic drugs
3. History of psychiatric disease
Interventions Group FA (17 participants): intravenous fentanyl 10 mcg/kg 5 minutes before induc-
tion and equal volume of normal saline after incision and removal of the uterus
Group SA (17 participants): intravenous sufentanil 1 mcg/kg 5 minutes before induc-
tion and equal volume of normal saline after incision and removal of the uterus
Group FB (17 participants): intravenous fentanyl 10 mcg/kg after incision and normal
saline before induction and on removal of the uterus
Group SB (17 participants): intravenous sufentanil 1 mcg/kg after incision and normal
saline before induction and removal of the uterus
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Fassoulaki 1995 (Continued)
Group FC (17 participants): intravenous fentanyl 10mcg/kg after removal of the uterus
and normal saline before induction and after incision
Outcomes 1. Postoperative pain (0-to-10-centimetre VAS and 1-to-6 VRS at 30 minutes, 1, 1.
5, 2, 2.5, and 24 hours postoperatively)
2. Tme to analgesic request (minutes)
Notes Funding: not reported
Declarations of interest: not reported
Authors contacted: no
Other: once participant requested analgesia, their pain was no longer assessed until 24
hours, so some participants not included in early acute postoperative pain outcome.
Groups combined for the main analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Table of randomnumbers by computerized
statistical package. Quote: “according to a
randomization schedule generated by a ta-
ble of random numbers bymeans of a com-
puterized statistical package”
Allocation concealment (selection bias) Unclear risk Sealed envelope.No further details. Quote:
“the contents of a sealed envelope indicated
the patient’s group, determined by the opi-
oid and the timing of its administration”
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Double-dummy placebo used, which
sounds similar in appearance. Quote: “the
study was double-blind. Three syringes,
one with fentanyl or sufentanil, and two
with normal saline of equal volume as
that containing opioid were prepared by
an anaesthetist, who was involved in the
patient randomization (opening of the en-
velopes) but not in its anaesthesia, pain as-
sessment or data collection”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Blinded. Quote: “all other anaesthetists,
anaesthetic nurses and patients were un-
aware of the group to which the patient was
assigned. Postoperative painwas assessed by
an independent observer, who was not in-
volved in patient randomization or anaes-
thesia administration”
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Fassoulaki 1995 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants analysed. Some partici-
pants missing from early pain score data
but numbers similar between groups
Selective reporting (reporting bias) Unclear risk No protocol or trial registration
Other bias Low risk Sufentanil groups had longer surgery but
should cancel out on analysis
Gerlach 2003
Methods Study design: parallel-group randomized controlled trial
Sample size: 48
Country: Germany
Setting: secondary care hospital
Dates conducted: not reported
Postoperative opioid used and delivery: PCA piritramide
Pain score collection: blinded interviewer
Concurrent postoperative analgesics: none reported
Participants Inclusion criteria
1. ASA 1 or 2 undergoing lumbar spinal surgery
Exclusion criteria
1. Individuals aged over 60 years
2. Liver disorder or renal disease
3. Known drug or alcohol abuse
4. Current administration of opioid analgesics
5. Known allergies to study drugs
Interventions Group R5 (16 participants): intravenous remifentanil 0.2 mcg/kg/min administered
over a 5-minute period before induction. After a 15-minute break, anaesthesia was started
with an infusion of 0.25 mcg/kg/min remifentanil followed by a continuous infusion of
0.25 mcg/kg/min until the end of anaesthesia
Group R20 (16 participants): intravenous remifentanil 0.05 mcg/kg/min was admin-
istered over a period of 20 minutes before induction and then same regimen as R5
Group RL (15 participants): 10 minutes after skin incision intravenous remifentanil
0.2 mcg/kg/min was administered for 5 minutes followed by an infusion of 0.5 mcg/kg/
min for 50 minutes. The infusion was then reduced to 0.25 mcg/kg/min and continued
until the end of anaesthesia
All groups had similar total doses of remifentanil.
Outcomes 1. Postoperative pain (NRS 0 to 15 at 1, 2, 3, 4, 5, 6, and 24 hours)
2. Piritramide consumption (mg, reported at 2, 4, 6, and 24 hours)
3. Adverse events (blood pressure (mmHg), heart rate (beats per minute), sedation
(Ramsey sedation scale), intraoperative awareness (yes/no), nausea and vomiting (yes/
no) at 1 hourly intervals up to 6 hours and again at 24 hours)
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Gerlach 2003 (Continued)
Notes Funding: departmental funds
Declarations of interest: not reported
Authors contacted: yes, although no reply
Other: postoperative pain converted to a 0-to-10 scale. Data extracted from graphs
using computer software. R5 and R20 groups combined for main analysis. We contacted
authors for further information but received no response
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details. Quote: “participants were ran-
domly assigned to 1 of 3 study groups”
Allocation concealment (selection bias) Unclear risk No mention
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No double-dummy placebo used.
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Blinded. Quote: “the assessment was per-
formedby a single interviewer, whowas un-
aware of the study medication”
Incomplete outcome data (attrition bias)
All outcomes
Low risk 1 participant dropped out of postincision
group due to protocol violation, which was
unlikely to cause bias. Quote: “of the 48
patients enrolled in the study, 1 had to be
excluded because the study protocol was vi-
olated: the surgery lasted less than 50 min-
utes, and thus the patient could not receive
the complete remifentanil infusion as de-
scribed for group RL”
Selective reporting (reporting bias) Unclear risk No protocol or trial registration
Other bias Low risk Longer surgery in postincision group, al-
though this was of little clinical signifi-
cance. Quote: “there were no significant
differences between the groupswith respect
to demographic data, duration of surgery
and anaesthesia and type of surgical proce-
dure”
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Griffin 1997
Methods Study design: parallel-group randomized controlled trial
Sample size: 38
Country: Ireland
Setting: secondary care hospital
Dates conducted: not reported
Postoperative opioid used and delivery: 2 mg intravenous morphine in recovery then
PCA morphine on ward
Pain score collection: blinded assessor
Concurrent postoperative analgesics: no other analgesia used
Participants Inclusion criteria
1. ASA 1 or 2 and admitted for elective total abdominal hysterectomy
Interventions Group PRE (18 participants): intravenous alfentanil 70 mcg/kg 15 minutes before
surgical incision and intravenous saline 15 minutes postincision
Group POST (16 participants): saline 15 minutes before incision and intravenous
alfentanil 70 mcg/kg 15 minutes after incision
Outcomes 1. Postoperative pain (0-to-200-millimetre VAS at 6, 12, 24, 48, and 72 hours)
2. Morphine consumption (mg in recovery and at 6, 12, 24, 48, and 72 hours)
3. Intraoperative hypotension (yes/no)
4. Nausea and vomiting (yes/no)
5. Pruritus (yes/no)
6. Respiratory depression (yes/no)
Notes Funding: supported by Abbott Research Endowment (Royal College of Surgeons, Ire-
land)
Declarations of interest: not reported
Authors contacted: no
Other: pain score data extracted from graphs using computer software. Pain score data
presented in graphs as 0-to-10-centimetre VAS. Standard deviation for morphine con-
sumption estimated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Unclear how sequence was generated.
Quote: “participants were allocated using
sealed envelopes to one of two groups”
Allocation concealment (selection bias) Unclear risk No details. Quote: “participants were allo-
cated using sealed envelopes to one of two
groups”
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Placebo sounds similar in appearance based
on description.Quote: “a randomized dou-
ble-blind design was used with both pa-
tients and postoperative assessors blinded
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to intraoperative management”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Postoperative assessors blinded. Quote: “a
randomized double-blind design was used
with both patients and postoperative as-
sessors blinded to intraoperative manage-
ment”
Incomplete outcome data (attrition bias)
All outcomes
High risk 4 participants excluded, some for rea-
sons that could have influenced outcome.
Quote: “of the 38 randomized patients, 4
were withdrawn from the study (1 from
Group PRE and 3 from Group POST). 2
patients were withdrawn because of nau-
sea and vomiting and two because of sur-
gical complications necessitating return to
the operating room”
Selective reporting (reporting bias) Unclear risk No protocol or trial registration
Other bias Low risk Similar baseline characteristics and no in-
dustry funding.Quote: “this workwas sup-
ported in part by the Abbott Research En-
dowment, Faculty of Anaesthetists, Royal
College of Surgeons in Ireland”
Kiliçkan 2001
Methods Study design: parallel-group randomized controlled trial
Sample size: 60
Country: Turkey
Setting: secondary care hospital
Dates conducted: not reported
Postoperative opioid used and delivery: 2 mg morphine bolus in recovery then PCA
morphine
Pain score collection: no mention
Concurrent postoperative analgesics: none reported
Participants Inclusion criteria
1. Female participants
2. ASA 1 or 2
3. Aged 20 to 60 years
4. Undergoing total abdominal hysterectomy, with or without salpingo-opherectomy
Exclusion criteria
1. Chronic pain
2. Chronic analgesic use
3. Unco-operative individuals
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Kiliçkan 2001 (Continued)
Interventions Group I (20 participants): received 0.15 mg/kg of morphine following induction and
placebo during peritoneal closure
Group II (20 participants): received placebo following induction and 0.15 mg/kg of
morphine during peritoneal closure
Group III (20 participants): received placebo both during induction and peritoneal
closure
Outcomes 1. Morphine consumption (mg at 24 hours)
2. Postoperative pain (0-to-100-millimetre VAS at 3, 6, 12, 24, and 48 hours)
3. Sedation (0-to-100-millimetre VAS at 4, 24, and 48 hours)
4. Nausea and vomiting (0-to-100-millimetre VAS at 4, 24, and 48 hours)
5. Plasma cortisol (nmol/L at preoperative afternoon and morning, 4 hours, and 1st
day postoperatively)
6. Plasma leukocytes (preoperatively and at 30 minutes, 4, 8, 24 hours after surgery)
7. Plasma glucose (preoperatively and at 30 minutes, 4, 8, 24 hours after surgery)
Notes Funding: not reported
Declarations of interest: not reported
Authors contacted: no
Other: only data from Group I versus II included in review. Pain data extracted from
graph using computer software
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No mention
Allocation concealment (selection bias) Low risk Pharmacy controlled. Quote: ”before start-
ing the study our hospital pharmacy pre-
pared 120 pairs of ampoules, each am-
poule containing 10 ml of colourless so-
lution. Each pair of ampoules was boxed
and numbered consecutively, 1 to 120, and
comprised one ampoule labelled ’induc-
tion’ and one labelled ’closure”
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Similar ampoules and double-dummy
placebo used. Quote: “the researchers did
not know the content two pairs of ampules;
only the pharmacy knew the random dis-
tribution”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Likely blinded due to above information
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Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No mention
Selective reporting (reporting bias) Unclear risk No protocol or trial registration
Other bias Low risk Similar baseline characteristics. Quote:
“there was no difference in demographics,
type and duration between groups”
Koprulu 2015
Methods Study design: parallel-group randomized controlled trial
Sample size: 50
Country: Turkey
Setting: secondary care hospital
Dates conducted: 2012 to 2014
Postoperative opioid used and delivery: pethidine 1 mg/kg when VAS > 4
Pain score collection: not reported
Concurrent postoperative analgesics: paracetamol 15 mg/kg
Participants Inclusion criteria
1. Elective lower limb varicose vein surgery (saphenous vein stripping)
2. Aged 25 to 64 years of age
Exclusion criteria
1. History of chronic alcohol abuse
2. Regular analgesic use within 6 months
3. Chronic pain
4. Other systemic illness
Interventions Group 1 (25 participants): intravenous tramadol 1.5 mg/kg 15 minutes before induc-
tion and saline placebo after incision
Group 2 (25 participants): intravenous tramadol 1.5 mg/kg after incision and saline
placebo 15 minutes before induction
Outcomes 1. Postoperative pain (on a 0-to-10-centimetre VAS at extubation, before first
analgesic request, 6, 12, 18, and 24 hours)
2. Pethidine and paracetamol consumption (mg at 24 hours)
3. Time to first analgesic request (minutes)
4. Complications (arrhythmia, respiratory depression, convulsions, hypotension,
headache, dizziness, nausea, vomiting, and urinary retention (yes/no) at 24 hours)
Notes Funding: not reported
Declarations of interest: not reported
Authors contacted: yes, although no response received
Other: time to first analgesic request not reported as time to event. Turkish article that
was translated before data extraction. We contacted authors for further information but
received no response
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Koprulu 2015 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details. Quote: “two divided into equal
groups”
Allocation concealment (selection bias) Unclear risk No mention
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Double-dummy placebo of identical saline.
Quote: “the same volume of physiological
saline”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No mention
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants analysed. Numbers in ta-
bles match those randomized
Selective reporting (reporting bias) Unclear risk No protocol or trial registration
Other bias Low risk Similar groups and no industry funding.
Quote: “demographic differences between
the two groups statistical significance in
terms of findings and duration of operation
no difference was found”
Kurzova 2005
Methods Study design: parallel-group randomized controlled trial
Sample size: 63
Country: Czech Republic
Setting: secondary care hospital
Dates conducted: not reported
Postoperative opioid used and delivery: PCA morphine
Pain score collection: not reported
Concurrent postoperative analgesics: none reported
Participants Inclusion criteria
1. ASA 1 to 3 individuals undergoing abdominal hysterectomy with adnexectomy
Exclusion criteria
1. Known allergy to the drugs used
2. Unable to use PCA
Interventions Group M (21 participants): morphine 0.1 mg/kg 10 minutes before induction and
ketamine 0.6 mg/kg 10 minutes after laparotomy
Group K (21 participants): ketamine 0.6 mg/kg 10 minutes before induction and
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morphine 0.1 mg/kg 10 minutes after laparotomy
GroupMK (21 participants):morphine 0.1mg/kg and ketamine 0.6mg/kg 10minutes
before induction and normal saline 10 minutes after laparotomy
Outcomes 1. Morphine consumption (mg at 24 and 48 hours)
2. Postoperative pain (0-to-100 NRS for 48 hours)
Notes Funding: supported by grant IGA NL 7682-3 (source unclear)
Declarations of interest: not reported
Authors contacted: yes, and further information provided
Other: authors contacted and provided further information necessary for inclusion as
study unpublished. Although ketamine given, Group MK qualifies as preventive and
Group K as postincision. Time point for pain scores unclear so not included
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk States that “the patients were randomly di-
vided” but no details provided
Allocation concealment (selection bias) Unclear risk No mention
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk States that participants were blinded and
drugs were in coded syringes, and nor-
mal saline given as double-dummyplacebo.
Quote: “the patients and the staff were
blinded to the study group”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Staff were blinded. Quote: “the patients
and the staff were blinded to the study
group”
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants analysed
Selective reporting (reporting bias) Unclear risk No protocol or trial registration
Other bias Low risk Similar groups
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Lenz 2008
Methods Study design: parallel-group randomized controlled trial
Sample size: 100
Country: Norway
Setting: secondary care hospital
Dates conducted: not reported
Postoperative opioid used and delivery: PCA fentanyl (first 4 hours) then oxycodone 5
mg after
Pain score collection: not reported
Concurrent postoperative analgesics: paracetamol 2 g pre-medication then paracetamol
1 g and diclofenac 50 mg 6 hours after pre-medication, evening, and next morning
Participants Inclusion criteria
1. Adults (18 to 70 years)
2. Scheduled for endoscopic reconstruction of the anterior cruciate ligament
3. ASA 1 or 2
Exclusion criteria
1. Regular use of paracetamol, NSAIDs, corticosteroids, antiemetics, or opioids
2. Contraindications for NSAIDs
3. Obesity
4. Pregnancy
Interventions Group Pre (50 participants): 1.5 mcg/kg IV fentanyl before remifentanil infusion (at
induction) and 10 minutes before the end of surgery (3 mcg/kg in total)
Group Post (50 participants): saline placebo at induction and 3 mcg/kg IV fentanyl
10 minutes before the end of surgery
Outcomes 1. Opioid consumption (mcg fentanyl 0 to 4 hours then mg oxycodone 4 to 24
hours)
2. Postoperative pain (0-to-4 VRS at 1, 2, 3, and 4 hours after surgery)
3. Nausea and vomiting (yes/no, both 0 to 4 hours and 4 to 24 hours)
Notes Funding: departmental funding
Declarations of interest: 2 authors received compensation for lectures from Glaxo-
SmithKline
Authors contacted: we contacted authors for further information and received a response,
however no further data were available
Other: opioid consumption data extracted from graph using computer software. Pain
reported as median so included in narrative synthesis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated codes. Quote: “ran-
domization was based on computer-gener-
ated codes”
Allocation concealment (selection bias) Low risk Quote: “stored in sequentially numbered,
sealed envelopes. A nurse not participating
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in the handling or the evaluation of the
participant was responsible for opening the
envelopes and preparing the two coded sy-
ringes”
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Quote: “Group Pre, both syringes con-
tained fentanyl 1.5 mg/kg for participant’s
weight. In Group Post, syringe no. 1 con-
tained 0.9% saline (placebo) and syringe
no. 2 contained fentanyl 3.0 mg/kg based
on participant’s weight. Saline was used for
dilution so that the syringes contained the
same volume for participants with the same
weight”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Likely blinded based on above information
Incomplete outcome data (attrition bias)
All outcomes
Low risk Exclusions unlikely to cause bias. Quote:
“from 112 participants, 12 were excluded
because the surgical procedure did not pro-
ceed to repair as planned”
Selective reporting (reporting bias) Low risk NCT00241332. Primary outcomes pre-
stated. Quote: “the study was reported to
ClinicalTrials.gov ID: NCT00241332”
Other bias Low risk Similar groups and no industry funding.
Quote: “the demographic characteristics of
these 100 patients were similar in the two
groups”
Mansfield 1994
Methods Study design: parallel-group randomized controlled trial
Sample size: 62
Country: UK
Setting: secondary care hospital
Dates conducted: not reported
Postoperative opioid used and delivery: PCA morphine
Pain score collection: ward nurses
Concurrent postoperative analgesics: none reported
Participants Inclusion criteria
1. ASA 1 or 2
2. Scheduled for total abdominal hysterectomy with or without bilateral salpingo-
oophorectomy
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Mansfield 1994 (Continued)
Exclusion criteria
1. Known alcohol or drug abuse
2. History of chronic pain
3. Current treatment with NSAIDs
4. Previous psychiatric history
5. History of liver disease
6. Allergy to opioids
Interventions Group A (30 participants): intravenous alfentanil 7.5 mcg/kg at induction and 90
seconds before incision (15 mcg/kg total dose)
Group B (30 participants): intravenous 15 mcg/kg alfentanil 10 minutes after incision
Outcomes 1. Postoperative pain (0-to-100-millimetre VAS at 2, 6, and 24 hours)
2. Morphine consumption (mg at 2, 6, and 24 hours)
3. Intraoperative bradycardia (incidence and dose of atropine in mcg)
Notes Funding: not reported
Declarations of interest: not reported
Authors contacted:we contacted authors for further informationbut receivedno response
Other: data reported as median, so included in narrative synthesis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details. Quote: “after the pre-operative
visit participants were allocated randomly
to either the study or control group”
Allocation concealment (selection bias) Unclear risk No mention
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No placebo. Quote: “were recruited into
this single-blind, randomised study”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Blinded. Quote: “nurses were unaware of
each participant’s group allocation and
none of the investigators saw any partici-
pant postoperatively until the end of the
study period”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Unlikely to bias results due to low num-
bers. Quote: “one participant in the con-
trol group was withdrawn because of exces-
sive nausea and itch which was attributed
to morphine in the PCA. The data for one
participant were lost”
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Selective reporting (reporting bias) Unclear risk No protocol or trial registration
Other bias Low risk Similar baseline characteristics. No indus-
try funding
Mansfield 1996
Methods Study design: parallel-group randomized controlled trial
Sample size: 66
Country: UK
Setting: secondary care hospital
Dates conducted: not reported
Postoperative opioid used and delivery: PCA morphine
Pain score collection: not reported
Concurrent postoperative analgesics: none reported in first 24 hours
Participants Inclusion criteria
1. Females undergoing total abdominal hysterectomy with or without salpingo-
oopherectomy
2. ASA 1 or 2
3. Aged 18 to 70 years
4. Weighing 45 kg to 100 kg
Exclusion criteria
1. If individual requested exclusion
2. Organ dysfunction
3. Chronic pain
4. Regular opioids
5. NSAIDs
6. Drug/alcohol abuse
7. Psychiatric disorder
Interventions Group Pre-low (22 participants): intravenous morphine 0.15 mg/kg given during
induction and placebo at peritoneal closure
Group Pre-high (20 participants): intravenous morphine 0.3 mg/kg given during in-
duction and placebo at peritoneal closure
GroupPost (18 participants):placebo at induction and0.15mg/kg at peritoneal closure
Outcomes 1. Postoperative pain (1, 2, 4, 24, and 48 hours on 0-to-100-millimetre VAS and 0-
to-8 VRS at rest and movement)
2. Morphine consumption (mg at 24 and 48 hours)
3. Nausea, vomiting, and antiemetic requirement (all yes/no at 24 hours)
Notes Funding: not reported
Declarations of interest: not reported
Authors contacted:we contacted authors for further informationbut receivedno response
Other: results reported as median so included in narrative synthesis. Pain data extracted
from graph using computer software
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details
Allocation concealment (selection bias) Low risk Pharmacy controlled. Quote: “pharmacy
prepared 10ml colourless solutions which
were sequentially numbered”
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Double-dummy used. Quote: “pharmacy
prepared 10ml colourless solutions which
were sequentially numbered”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Blinded based on above information.
Quote: “all investigators were blinded to
the contents of the pair of ampoules”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Dropouts unlikely to bias results. 1 partic-
ipant from 1 group excluded due to severe
anxiety, but number too small to affect re-
sults
Selective reporting (reporting bias) Unclear risk No protocol or trial registration
Other bias Low risk Similar baseline characteristics
Millar 1998
Methods Study design: parallel-group randomized controlled trial
Sample size: 68
Country: UK
Setting: secondary care hospital
Dates conducted: not reported
Postoperative opioid used and delivery: PCA morphine
Pain score collection: not reported
Concurrent postoperative analgesics: no other analgesics given during 24 hours after
surgery
Participants Inclusion criteria
1. ASA 1 and 2 individuals
2. Aged under 60 years old
3. Undergoing hysterectomy with or without salpingo-oophorectomy
Exclusion criteria
1. Chronic pain
2. Alcohol or drug abuse
3. Psychiatric history
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Interventions Group Induction (30 participants): intravenous morphine 0.3 mg/kg at induction and
intravenous saline at incision
Group Incision (30 participants): intravenous saline at induction and intravenous
morphine 0.3 mg/kg at incision
Outcomes 1. Morphine consumption (mg in recovery and at 1, 2, 4, and 24 hours)
2. Postoperative pain (0-to-100-millimetre VAS and VRS at 1, 2, 4, 24, and 48
hours)
3. Nausea and vomiting (yes/no at 1, 2, 4, 24, and 48 hours)
Notes Funding: not reported
Declarations of interest: not reported
Authors contacted: we contacted authors for further information and received a response,
however no further data were available
Other: data reported as median so included in narrative synthesis. Nausea and vomiting
not reported. Could not use pain score data as graphs have contradictory legends on and
below the graph
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details
Allocation concealment (selection bias) Low risk Pharmacy controlled. Quote: “the hospital
pharmacy prepared”
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Double-dummy placebo that sounds simi-
lar in appearance. Quote: “and randomized
them so that the investigator did not know
if the morphine was given at induction or
incision”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not enough detail to assess
Incomplete outcome data (attrition bias)
All outcomes
High risk >10%of participants lost to follow-up, and
some for reasons that could have influenced
outcome. Quote: “one had a panic attack,
one developed respiratory depression”
Selective reporting (reporting bias) High risk Nausea and vomiting not reported
Other bias Low risk Similar baseline characteristics.Quote: “pa-
tients were similar”
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Pjevic 1999
Methods Study design: parallel-group randomized controlled trial
Sample size: 30
Country: Croatia
Setting: secondary care hospital
Dates conducted: not reported
Postoperative opioid used and delivery: intramuscular piritramide
Pain score collection: not reported
Concurrent postoperative analgesics: intramuscular metamizole 2500 mg
Participants Inclusion criteria
1. ASA 1 or 2 individuals undergoing open cholecystectomy
2. Aged 40 to 65 years old
Exclusion criteria
1. On analgesics
2. Addicted to alcohol or drugs
3. Chronic pain
4. Liver disease
Interventions Group 1 (15 participants): intravenous pethidine 1 mg/kg 5 minutes before induction
and equal volume of normal saline after peritoneal opening
Group 2 (15 participants): equal volume of normal saline 5 minutes before induction
and intravenous pethidine 1 mg/kg after peritoneal opening
Outcomes 1. Time to first analgesic request (minutes)
2. Piritramide and metamizole consumption (mg at 24 hours)
3. Postoperative pain (0-to-10-centimetre VAS before analgesia and at 4, 8, 12, and
24 hours)
Notes Funding: not reported
Declarations of interest: not reported
Authors contacted: no
Other: participants also receivedmetamizole for postoperative analgesia. Croatian article
was translated before data extraction. Early acute pain scores included from 4 hours
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details. Quote: “participants were di-
vided into two groups”
Allocation concealment (selection bias) Unclear risk No mention
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Similar double-dummy placebo
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Pjevic 1999 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No mention
Incomplete outcome data (attrition bias)
All outcomes
Low risk No dropouts
Selective reporting (reporting bias) Unclear risk No protocol or trial registration
Other bias Low risk Similar baseline characteristics
Pozos-Guillen 2007
Methods Study design: parallel-group randomized controlled trial
Sample size: 60
Country: Mexico
Setting: secondary care hospital
Dates conducted: not reported
Postoperative opioid used and delivery: N/A
Pain score collection: in clinic-submitted pain evaluations
Concurrent postoperative analgesics: dexamethasone 4 mg intramuscular before proce-
dure, paracetamol 500 mg to 1000 mg or ketorolac 10 mg (or intramuscular 30 mg)
depending on pain
Participants Inclusion criteria
1. Between the ages of 19 and 27 years
2. Undergoing elective removal of an impacted mandibular third molar surgery with
local anaesthesia
Exclusion criteria
1. Use of analgesics 12 hours before the treatment
2. History of seizure disorders
3. Pregnancy
4. Lactation
Interventions Group A (20 participants): intramuscular tramadol 100 mg 1 hour before surgery
Group B (20 participants): intramuscular tramadol 100 mg after surgery
Group C (20 participants): saline placebo
Outcomes 1. Postoperative pain (0-to-10-centimetre VAS at 6 and 24 hours)
2. Relief of pain (0-to-4 scale at 24 hours)
3. Analgesic consumption (mg ketorolac and mg paracetamol at 24 hours)
Notes Funding: funded by Universidad Autónoma San Luis Potosí; C0-FAI-04-3.4 and C04-
FAI-10-10.53
Declarations of interest: not reported
Authors contacted:we contacted authors for further informationbut receivedno response
Other: extracted fromgraphs using computer software.Unclearwhat errors bars represent
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Unclear details. Quote: “participants were
randomized”
Allocation concealment (selection bias) Unclear risk No mention
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No double-dummy placebo
Blinding of outcome assessment (detection
bias)
All outcomes
High risk No double-dummy placebo
Incomplete outcome data (attrition bias)
All outcomes
Low risk It appears that all participants were fol-
lowed up.
Selective reporting (reporting bias) High risk Adverse events not fully reported.
Other bias Low risk Similar groups and no industry funding.
Quote: “demographic characteristics of the
sample were similar between groups for age
and gender”
Richmond 1993
Methods Study design: parallel-group randomized controlled trial
Sample size: 76
Country: UK
Setting: secondary care hospital
Dates conducted: not reported
Postoperative opioid used and delivery: PCA morphine
Pain score collection: not reported
Concurrent postoperative analgesics: none reported
Participants Inclusion criteria
1. ASA 1 and 2
2. Undergoing elective total abdominal hysterectomy
Exclusion criteria
1. Chronic pain
2. Regular intake of analgesics
3. Psychiatric illness
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Richmond 1993 (Continued)
Interventions Group IV Pre (23 participants): intravenous morphine 10 mg administered at induc-
tion
Group IV Post (21 participants): intravenous morphine 10 mg administered at peri-
toneal closure
Also reports that saline placebo was used
Outcomes 1. Morphine consumption (mg at 24 hours)
2. Pain sensitivity and postoperative pain (rest and movement on 0-to-100-
millimetre VAS at 4, 24, and 48 hours)
Notes Funding: author recipient of Bristol-Myers Squibb research grant. Role in published
study unclear
Declarations of interest: as above
Authors contacted: no
Other: pain score data extracted from graph and standard deviations estimated. Study
also included a further group who were administered intramuscular morphine but we
did not include this group in review as different route of administration
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No mention. Quote: “patients were ran-
domly allocated”
Allocation concealment (selection bias) Low risk Performed by pharmacist. Quote: “were
randomly allocated by a pharmacist”
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Saline used as placebo. Pharmacy made up
studymedications blind.Quote: “the study
was double blind”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Reported as blinded.Quote: “the studywas
double blind”
Incomplete outcome data (attrition bias)
All outcomes
High risk Number of participants who dropped out
for the reasons listed and to which groups
they belonged is unclear from text. 1 rea-
son for dropout was severe nausea, which
could bias outcome ofmorphine consump-
tion. Quote: “16 were excluded ... or severe
nausea”
Selective reporting (reporting bias) Unclear risk No protocol or trial registration
Other bias Low risk Similar baseline characteristics. 1 of the in-
vestigators received industry funding, but
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it was unclear if the funding was specific
to this study. Quote: “the groups were not
statistically different”
Sarantopoulos 1996
Methods Study design: parallel-group randomized controlled trial
Sample size: 40
Country: Greece
Setting: secondary care hospital
Dates conducted: not reported
Postoperative opioid used and delivery: pethidine 1 mg/kg (no PCA)
Pain score collection: blinded nurses
Concurrent postoperative analgesics: propoxyphene 75 mg and paracetamol 600 mg
intramuscularly if pain insufficiently controlled
Participants Inclusion criteria
1. ASA 1 or 2
2. Admitted for elective abdominal hysterectomy
Exclusion criteria
1. Alcohol or drug abuse
2. History of chronic pain
3. Current treatment with analgesics
4. Psychiatric history
5. History of liver disease
Interventions GroupA (18 participants): intravenous sufentanil 1mcg/kg 5minutes before induction
and normal saline during round ligament ligation
Group B (21 participants): intravenous sufentanil 1 mcg/kg during round ligament
ligation and normal saline before induction
Outcomes 1. Analgesic consumption (mg pethidine and mg propoxyphene consumption at 24
hours)
2. Postoperative pain (0-to-10-centimetre VAS and 0-to-6 NRS at analgesic request,
4 hourly for 12 hours then at 24 hours)
3. Time to first analgesic request (minutes)
Notes Funding: not reported
Declarations of interest: not reported
Authors contacted: no
Other: time to analgesic request not time to event. Analgesic consumption standard de-
viations estimated as means for both analgesics were combined. Early acute postoperative
pain recorded from 4 hours postoperatively
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk Computer-generated random numbers.
Quote: “using a computer-created table of
random numbers”
Allocation concealment (selection bias) Unclear risk Envelope used; no further details. Quote:
“an investigator who was not involved in
administering the patient’s anaesthesia or
assessing postoperative pain opened an en-
velope containing the group assignment for
each prospective patient”
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Double-dummy placebo used, which
sounds similar. Quote: “the patient, anaes-
thesiologists and nurses involved in anaes-
thesia, postoperative care, and pain assess-
ment were blinded to group assignment”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Blinded. Quote: “the patient, anaesthesi-
ologists and nurses involved in anaesthe-
sia, postoperative care, and pain assessment
were blinded to group assignment”
Incomplete outcome data (attrition bias)
All outcomes
Low risk 1 participant withdrawn due to confusion,
unlikely to bias. Quote: “one patient as-
signed to the SA groupwaswithdrawn from
the study. This was due to mental confu-
sion and impaired cooperation”
Selective reporting (reporting bias) Unclear risk No protocol or trial registration
Other bias Low risk Similar baseline characteristics. Quote: “no
significant differences were found between
the two groups”
Sert 2012
Methods Study design: parallel-group randomized controlled trial
Sample size: 50
Country: Turkey
Setting: secondary care hospital
Dates conducted: June 2009 to February 2010
Postoperative opioid used and delivery: PCA tramadol if VAS > 3
Pain score collection: not reported
Concurrent postoperative analgesics: none reported
Participants Inclusion criteria
1. ASA 1 or 2
2. Aged between 20 and 60 years
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Sert 2012 (Continued)
3. Scheduled for elective subtotal thyroidectomy or breast-conserving surgery
Exclusion criteria
1. Requiring radical neck dissection
2. Requiring axillary lymph node dissection
3. Receiving regular sedative or narcotic medications
4. Received systemic opioids within 48 hours of surgery
5. Significant history of cardiovascular, hepatic, or renal disease
6. Allergic to anaesthetics
Interventions Group P (25 participants): intravenous pethidine 1 mg/kg before induction
Group I (25 participants): intravenous pethidine 1 mg/kg 20 minutes before the end
of surgery
Outcomes 1. Postoperative pain (30 minutes and 1, 2, 6, 12, and 24 hours on 0-to-10-
centimetre VAS)
2. Tramadol consumption (mg at 24 hours)
3. Time to first analgesic (minutes)
4. Side effects (intraoperative bradycardia, intraoperative hypotension, respiration
depression, pruritus and allergic reaction, yes/no at 24 hours)
5. Sedation (4-point scale up to 24 hours)
Notes Funding: not reported
Declarations of interest: not reported
Authors contacted:we contacted authors for further informationbut receivedno response
Other: unclear what average values represent on graph of postoperative pain scores. Time
to first analgesic request not time to event. Sedation not used as ordinal scale. Results
reported as median so included in narrative synthesis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-gener-
ated randomization. Quote: “the patients
were randomly allocated using a computer-
generated randomization scheme to 1 of 2
groups”
Allocation concealment (selection bias) Unclear risk No mention
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No double-dummy placebo used. Quote:
“an anesthesiologist who was not involved
in the data collection process prepared the
study solutions”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No mention of postoperative data col-
lection. Quote: “another anesthesiologist,
who was blinded to the treatment group al-
location, collected the data during the op-
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Sert 2012 (Continued)
erations”
Incomplete outcome data (attrition bias)
All outcomes
Low risk All participants analysed. Quote: “no pa-
tient was excluded from the study for any
reason”
Selective reporting (reporting bias) Unclear risk No protocol or trial registration
Other bias Low risk Similar baseline characteristics. Quote:
“there were no statistically significant dif-
ferences between the 2 groups regarding
sex, age, weight, height, ASA physical sta-
tus, duration of anesthesia and surgery, or
types of surgery”
Shen 2008
Methods Study design: parallel-group randomized controlled trial
Sample size: 317
Country: China
Setting: secondary care hospital
Dates conducted: not reported
Postoperative opioid used and delivery: PCA morphine
Pain score collection: not reported
Concurrent postoperative analgesics: none
Participants Inclusion criteria
1. ASA 1 or 2
2. Aged 18 to 65 years old
3. Underwent elective lumpectomy
Exclusion criteria
1. Allergy to opioids
2. History of use of centrally acting drugs
3. Chronic pain
4. Psychiatric disorders
5. Pregnancy
6. Not willing to take part
7. Individuals with a score under 6 out of 10 in PACU (measuring somnolence,
respiration, movement, colour, and blood pressure on 0-to-2 scales)
8. Oxygen saturation was 92% or lower
9. Monoamine oxidase inhibitor use within 14 days
10. Alcohol abuse
11. Opioid-dependent individuals
Interventions Group T1 (148 participants): intravenous tramadol 100 mg in 10 mL 15 minutes
before surgery and the same volume of saline 15 minutes before the end of surgery
Group T2 (151 participants): 10 mL of saline was injected 15 minutes before surgery
and the same volume of intravenous tramadol 100 mg 15 minutes before the end of
surgery
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Shen 2008 (Continued)
Outcomes 1. Postoperative pain (0-to-100-millimetre VAS every hour between 1 and 12 hours
then every 6 hours until 24 hours)
2. Morphine consumption (mg at 24 hours)
3. Patient satisfaction (1-to-100-millimetre VAS at 24 hours)
4. Nausea, vomiting, dry mouth, dizziness, drowsiness, pruritus, sweating,
constipation, urinary retention, respiratory depression, meiosis, and cognitive
impairment (all yes/no at 24 hours)
Notes Funding: not reported
Declarations of interest: not reported
Authors contacted:we contacted authors for further informationbut receivedno response
Other: morphine consumption reported as median so included in narrative synthesis.
Pain data extracted from graph using computer software
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Participants randomly assigned, although
no details as to how this was achieved.
Quote: “all enrolled patients were ran-
domly assigned into one of two groups ac-
cording to SNOSE way”
Allocation concealment (selection bias) Low risk Sequentially numbered, opaque, sealed en-
velopes
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Similar double-dummy placebo. Quote: “.
.. and the same volume of saline before the
end of operation”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Likely blindedbased on information above.
Quote: “all research staff, data collection
doctors and nurses and drug delivery per-
sonnel were kept away from the contents
of the syringe”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Similar dropouts, and reasons unlikely to
bias
Selective reporting (reporting bias) Unclear risk No protocol or trial registration
Other bias Low risk Similar baseline characteristics. Quote:
“the demographic, background, surgical,
anesthesia and intraoperative management
data, baseline vital signs (all were within the
physiological ranges throughout the anes-
thesia and surgical process) were not signif-
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Shen 2008 (Continued)
icantly different between the two groups”
Wilson 1994
Methods Study design: parallel-group randomized controlled trial
Sample size: 40
Country: UK
Setting: secondary care hospital
Dates conducted: not reported
Postoperative opioid used and delivery: 2 mg morphine boluses in recovery then PCA
morphine
Pain score collection: no mention
Concurrent postoperative analgesics: no other analgesia
Participants Inclusion criteria
1. Undergoing elective total abdominal hysterectomy via a transverse lower
abdominal incision
2. ASA 1 or 2
3. Aged between 25 and 65 years
4. Weighed between 45 kg and 100 kg
Interventions Group A (assumed 20 participants): IV 40 mcg/kg alfentanil on induction and 0.9%
saline 1 minute after incision
Group B (assumed 20 participants): IV 40 mcg/kg alfentanil 1 minute after incision
and 0.9% saline on induction
Outcomes 1. Morphine consumption (mg in recovery and 4, 8, 12, 16, 20, and 24 hours
postoperatively)
2. Postoperative pain (0-to-100-millimetre VAS at 24 hours)
Notes Funding: not reported
Declarations of interest: not reported
Authors contacted: we contacted authors for further information and received a response,
however no further data were available
Other: pain reported as median so included in narrative synthesis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details. Quote: ’participants were ran-
domly allocated to one of two groups’
Allocation concealment (selection bias) Unclear risk No mention
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Double-dummy placebo used and meth-
ods state: “the anaesthetist, participant and
the assessor were blind to the participant’s
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Wilson 1994 (Continued)
group allocation”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Blinded as above. Quote: “the anaesthetist,
participant and the assessor were blind to
the participant’s group allocation” and “Re-
covery staff were blind to the patient’s
group allocation”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No mention
Selective reporting (reporting bias) Unclear risk No protocol or trial registration
Other bias Low risk Similar baseline characteristics. Quote:
“there were no differences between the
groups in the mean age, weight, time from
induction to incision and length of opera-
tion”
Wordliczek 2002
Methods Study design: parallel-group randomized controlled trial
Sample size: 90
Country: Poland
Setting: secondary care hospital
Dates conducted: not reported
Postoperative opioid used and delivery: PCA tramadol
Pain score collection: not reported
Concurrent postoperative analgesics: none reported
Participants Inclusion criteria
1. Scheduled for elective colon surgery (hemicolectomy)
Exclusion criteria
1. Severe hepatic, renal, cardiovascular, or psychological disorders
2. Unable to rate the VAS score
3. Unable to use the PCA pump
Interventions Group I (30 participants): 100 mg IV tramadol 15 minutes before induction
Group II (30 participants): 100 mg IV tramadol after peritoneal closure
Group Control (30 participants): 100 mg IV tramadol immediately after operation
Outcomes 1. Tramadol consumption (mg in early postoperative period)
2. Postoperative pain (VAS on initial activation of PCA device, 2, 4, 8, 12 hours
postoperatively, and the morning of the day following surgery)
3. Time to analgesia (minutes)
4. Drowsiness/sedation (yes/no postoperatively)
5. Nausea and vomiting (yes/no postoperatively)
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Wordliczek 2002 (Continued)
Notes Funding: supported by grant WL/241/KL/L from Collegium Medicum Jagiellonian
University, Kraków, Poland
Declarations of interest: none reported
Authors contacted:we contacted authors for further informationbut receivedno response
Other: only results from Group I (preventive) and control group compared. Sedation
not analysed as dichotomous outcome. Time to analgesic request standard deviations
estimated as unclear from graph
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details. Quote: “participants were ran-
domly allocated into three groups”
Allocation concealment (selection bias) Unclear risk No mention
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Interventions given at different times.
Quote: “30 patients (I group) were admin-
istered 100 mg of tramadol iv 15 min-
utes before induction of general anesthesia.
The patients of II group were administered
100 mg of tramadol iv immediately after
peritoneal closure. In order to determine
the influence of the inhibition of phase II
(inflammatory response in the postopera-
tive period) on nociceptive stimulation, pa-
tients in control group (30 patients) re-
ceived 100 mg of tramadol iv immediately
after operation”
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Likely unblinded based on above informa-
tion
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No mention of any dropouts
Selective reporting (reporting bias) Unclear risk No protocol or trial registration
Other bias Low risk Similar baseline characteristics and no re-
ported conflicts of interest
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Zand 2012
Methods Study design: parallel-group randomized controlled trial
Sample size: 60
Country: Iran
Setting: secondary care hospital
Dates conducted: not reported
Postoperative opioid used and delivery: 1 mg morphine boluses in recovery then PCA
morphine
Pain score collection: blinded nurse
Concurrent postoperative analgesics: no other analgesics
Participants Inclusion criteria
1. Aged 40 to 70 years old
2. ASA 1 or 2
3. Scheduled to undergo elective open unilateral nephrolithotomy
Exclusion criteria
1. History of acute or chronic kidney injury
2. Drug abuse
3. Received any analgesic medications during the previous 48 hours
4. Unable to use a PCA device
Interventions Group E (30 participants): intravenous morphine 0.1 mg/kg immediately after intu-
bation
Group L (30 participants): intravenous morphine 0.1 mg/kg 20 to 30 minutes before
the end of surgery
Outcomes 1. Postoperative pain (in recovery then 4 hourly until 24 hours on a 0-to-10 NRS)
2. Morphine consumption (mg at 24 hours)
Notes Funding: not reported
Declarations of interest: not reported
Authors contacted:we contacted authors for further informationbut receivedno response
Other: graph for pain did not includemedian for 24 hours. Standard deviations estimated
for 24-hour morphine consumption and are calculated by adding PACU morphine to
morphine consumption on the ward
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random numbers.
Quote: “randomization of the subjects us-
ing a computer generated random num-
bers”
Allocation concealment (selection bias) Unclear risk No mention
Blinding of participants and personnel
(performance bias)
All outcomes
High risk No double-dummy placebo used. Quote:
“both groups received 0.1mg/kgmorphine
intravenously diluted in normal saline to
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Zand 2012 (Continued)
a concentration of 1 mg/ml at 2 different
times; in the first group (group E) imme-
diately after intubation and in the second
group (group L) 20-30 min before the an-
ticipated end of operation”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Blinded outcome assessment. Quote: “the
pain score was recorded according to nu-
merical rating scale by a nurse, who was
blinded to the patient study assignments”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “all 60 participants completed the
study”
Selective reporting (reporting bias) Low risk ACTRN: 12609000570280. Outcomes
pre-stated and fully reported
Other bias Low risk Similar baseline characteristics. Quote:
“both groups were similar with respect to
age, weight, gender, duration of anesthe-
sia, and surgery and hemodynamic vari-
ables during the operation”
ASA: American Society of Anesthesiologists
IV: intravenous
N/A: not applicable
NRS: numeric rating scale
NSAIDs: non-steroidal anti-inflammatory drugs
PACU: postanaesthesia care unit
PCA: patient-controlled analgesia
VAS: visual analogue scale
VRS: verbal rating scale
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Collis 1995 Part of the postincision dose was given before incision.
60Pre-emptive and preventive opioids for postoperative pain in adults undergoing all types of surgery (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Characteristics of studies awaiting assessment [ordered by study ID]
Espi 2004
Methods Study design: parallel-group randomized controlled trial
Sample size: 20
Country: not reported
Setting: not reported
Dates conducted: not reported
Participants Inclusion criteria
1. ASA 1 or 2 women undergoing total abdominal hysterectomy
Interventions Group A: morphine 0.2 mg/kg at induction
Group B:morphine 0.2 mg/kg on removal of the uterus
Outcomes 1. Time to eye opening
2. Time to extubation
3. Time to first words
4. Postoperative pain (0-to-100-millimetre VAS)
5. Morphine consumption (unclear time points)
6. Sedation (Ramsey sedation scale)
7. Time to first analgesic request (minutes)
8. Adverse events
Notes Funding: not reported
Declarations of interest: not reported
Authors contacted: we contacted authors for further information but received no response
Other: conference abstract. Insufficient information from abstract to include study in review
Nagasaka 1996
Methods Study design: parallel-group randomized controlled trial
Sample size: 46
Country: not reported
Setting: not reported
Dates conducted: not reported
Participants Inclusion criteria
1. Abdominal hysterectomy
Interventions Group A (23 participants): 30 mg or 60 mg pentazocine before surgical incision
Group B (23 participants): 30 mg or 60 mg pentazocine after surgical incision
Outcomes 1. Postoperative pain (on 0-to-10-centimetre VAS at 24 hours)
2. Pentazocine consumption (mg at 24 hours)
Notes Funding: not reported
Declarations of interest: not reported
Authors contacted: we contacted authors for further information but received no response
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Nagasaka 1996 (Continued)
Other: full text unavailable and abstract reports insufficient data to extract results. Abstract reports no significant
difference in pain scores or analgesic consumption
ASA: American Society of Anesthesiologists
VAS: visual analogue scale
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D A T A A N D A N A L Y S E S
Comparison 1. Preventive versus postincision opioids for postoperative pain
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Early acute postoperative
pain (within 6 hours
postoperatively)
10 706 Mean Difference (IV, Random, 95% CI) 0.11 [-0.32, 0.53]
2 Nausea and vomiting (long
term)
3 121 Risk Ratio (M-H, Random, 95% CI) 0.90 [0.58, 1.39]
3 Late acute postoperative pain (24
to 48 hours postoperatively)
9 668 Mean Difference (IV, Random, 95% CI) -0.06 [-0.13, 0.01]
4 24-hour morphine consumption
(mg)
11 526 Mean Difference (IV, Random, 95% CI) -4.91 [-9.39, -0.44]
5 Time to first analgesic request
(minutes)
6 298 Mean Difference (IV, Random, 95% CI) -8.15 [-19.45, 3.14]
6 Pruritus (long term) 3 383 Risk Ratio (M-H, Random, 95% CI) 0.75 [0.40, 1.43]
7 Bradycardia (incidence) 2 112 Risk Ratio (M-H, Random, 95% CI) 0.33 [0.01, 7.88]
8 Bradycardia (mean dose of
chronotrope in mcg)
2 112 Mean Difference (IV, Random, 95% CI) -9.68 [-28.65, 9.29]
9 Hypotension (incidence) 2 88 Risk Ratio (M-H, Random, 95% CI) 1.08 [0.25, 4.73]
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Analysis 1.1. Comparison 1 Preventive versus postincision opioids for postoperative pain, Outcome 1 Early
acute postoperative pain (within 6 hours postoperatively).
Review: Pre-emptive and preventive opioids for postoperative pain in adults undergoing all types of surgery
Comparison: 1 Preventive versus postincision opioids for postoperative pain
Outcome: 1 Early acute postoperative pain (within 6 hours postoperatively)
Study or subgroup Preventive Post-incision
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Fassoulaki 1995 25 6.2 (1.95) 38 4.21 (2.37) 9.1 % 1.99 [ 0.92, 3.06 ]
Gerlach 2003 32 6.52 (4.35) 15 6.1 (2) 4.4 % 0.42 [ -1.40, 2.24 ]
Griffin 1997 18 4.42 (1.8) 16 3.82 (1.8) 7.8 % 0.60 [ -0.61, 1.81 ]
Kili kan 2001 20 3.9 (1.8) 20 4.9 (1.8) 8.7 % -1.00 [ -2.12, 0.12 ]
Koprulu 2015 25 3.4 (0.9) 25 3.2 (1.1) 15.7 % 0.20 [ -0.36, 0.76 ]
Pjevic 1999 15 4.4 (1.5) 15 5 (1.6) 8.7 % -0.60 [ -1.71, 0.51 ]
Richmond 1993 23 3.64 (0.9) 21 3.82 (1.8) 11.5 % -0.18 [ -1.03, 0.67 ]
Sarantopoulos 1996 18 6.7 (2.5) 21 5.8 (2.5) 5.5 % 0.90 [ -0.67, 2.47 ]
Shen 2008 148 1 (0.6) 151 1.17 (0.4) 21.2 % -0.17 [ -0.29, -0.05 ]
Wordliczek 2002 30 5.5 (2.5) 30 5.8 (2.5) 7.4 % -0.30 [ -1.57, 0.97 ]
Total (95% CI) 354 352 100.0 % 0.11 [ -0.32, 0.53 ]
Heterogeneity: Tau2 = 0.22; Chi2 = 23.29, df = 9 (P = 0.01); I2 =61%
Test for overall effect: Z = 0.50 (P = 0.62)
Test for subgroup differences: Not applicable
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Analysis 1.2. Comparison 1 Preventive versus postincision opioids for postoperative pain, Outcome 2
Nausea and vomiting (long term).
Review: Pre-emptive and preventive opioids for postoperative pain in adults undergoing all types of surgery
Comparison: 1 Preventive versus postincision opioids for postoperative pain
Outcome: 2 Nausea and vomiting (long term)
Study or subgroup Preventive Post-incision Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Gerlach 2003 3/32 2/15 6.7 % 0.70 [ 0.13, 3.78 ]
Griffin 1997 4/18 3/16 10.5 % 1.19 [ 0.31, 4.51 ]
Mansfield 1996 13/22 12/18 82.8 % 0.89 [ 0.55, 1.43 ]
Total (95% CI) 72 49 100.0 % 0.90 [ 0.58, 1.39 ]
Total events: 20 (Preventive), 17 (Post-incision)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.25, df = 2 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 0.48 (P = 0.63)
Test for subgroup differences: Not applicable
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Analysis 1.3. Comparison 1 Preventive versus postincision opioids for postoperative pain, Outcome 3 Late
acute postoperative pain (24 to 48 hours postoperatively).
Review: Pre-emptive and preventive opioids for postoperative pain in adults undergoing all types of surgery
Comparison: 1 Preventive versus postincision opioids for postoperative pain
Outcome: 3 Late acute postoperative pain (24 to 48 hours postoperatively)
Study or subgroup Preventive Post-incision
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Fassoulaki 1995 34 3.9 (1.97) 51 3.8 (1.97) 0.6 % 0.10 [ -0.75, 0.95 ]
Gerlach 2003 32 2.27 (2.41) 15 3.39 (3.76) 0.1 % -1.12 [ -3.20, 0.96 ]
Griffin 1997 18 3 (2.2) 16 3 (2.2) 0.2 % 0.0 [ -1.48, 1.48 ]
Kili kan 2001 20 0.9 (0.6) 20 0.9 (0.6) 3.4 % 0.0 [ -0.37, 0.37 ]
Koprulu 2015 25 1.8 (1.1) 25 1.7 (0.9) 1.5 % 0.10 [ -0.46, 0.66 ]
Pjevic 1999 15 1.9 (1.1) 15 1.9 (0.7) 1.1 % 0.0 [ -0.66, 0.66 ]
Richmond 1993 23 3.14 (1.9) 21 2.56 (2) 0.4 % 0.58 [ -0.58, 1.74 ]
Sarantopoulos 1996 18 3.1 (1.9) 21 2.5 (2) 0.3 % 0.60 [ -0.63, 1.83 ]
Shen 2008 148 0.29 (0.2) 151 0.36 (0.4) 92.3 % -0.07 [ -0.14, 0.00 ]
Total (95% CI) 333 335 100.0 % -0.06 [ -0.13, 0.01 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 3.96, df = 8 (P = 0.86); I2 =0.0%
Test for overall effect: Z = 1.71 (P = 0.088)
Test for subgroup differences: Not applicable
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Analysis 1.4. Comparison 1 Preventive versus postincision opioids for postoperative pain, Outcome 4 24-
hour morphine consumption (mg).
Review: Pre-emptive and preventive opioids for postoperative pain in adults undergoing all types of surgery
Comparison: 1 Preventive versus postincision opioids for postoperative pain
Outcome: 4 24-hour morphine consumption (mg)
Study or subgroup Favours preventive Post-incision
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Gerlach 2003 32 26.53 (15) 15 41.6 (15) 9.1 % -15.07 [ -24.27, -5.87 ]
Griffin 1997 18 60.4 (21) 16 56.7 (21) 5.9 % 3.70 [ -10.44, 17.84 ]
Kili kan 2001 20 43 (6.45) 20 54.3 (8.44) 12.7 % -11.30 [ -15.96, -6.64 ]
Koprulu 2015 25 7.66 (1.33) 25 7.39 (1.57) 14.6 % 0.27 [ -0.54, 1.08 ]
Kurzova 2005 21 22.6 (7) 21 34.1 (12.1) 11.6 % -11.50 [ -17.48, -5.52 ]
Lenz 2008 50 35.4 (15) 50 37.16 (15) 11.7 % -1.76 [ -7.64, 4.12 ]
Pjevic 1999 15 0 (0) 15 0 (0) Not estimable
Richmond 1993 23 38.04 (15.44) 21 48.38 (18.42) 8.4 % -10.34 [ -20.43, -0.25 ]
Sarantopoulos 1996 18 25.4 (15) 21 25.5 (15) 8.9 % -0.10 [ -9.54, 9.34 ]
Wilson 1994 20 57.2 (20.6) 20 59.3 (19.8) 6.8 % -2.10 [ -14.62, 10.42 ]
Zand 2012 30 33.1 (15) 30 31.3 (15) 10.3 % 1.80 [ -5.79, 9.39 ]
Total (95% CI) 272 254 100.0 % -4.91 [ -9.39, -0.44 ]
Heterogeneity: Tau2 = 35.50; Chi2 = 51.37, df = 9 (P<0.00001); I2 =82%
Test for overall effect: Z = 2.15 (P = 0.031)
Test for subgroup differences: Not applicable
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Analysis 1.5. Comparison 1 Preventive versus postincision opioids for postoperative pain, Outcome 5 Time
to first analgesic request (minutes).
Review: Pre-emptive and preventive opioids for postoperative pain in adults undergoing all types of surgery
Comparison: 1 Preventive versus postincision opioids for postoperative pain
Outcome: 5 Time to first analgesic request (minutes)
Study or subgroup Preventive Post-incision
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Fassoulaki 1995 34 65.5 (40.34) 51 85.33 (62.87) 14.0 % -19.83 [ -41.78, 2.12 ]
Griffin 1997 18 105 (12) 16 91 (37) 16.1 % 14.00 [ -4.96, 32.96 ]
Koprulu 2015 25 24.21 (8.2) 25 42.18 (9.8) 28.0 % -17.97 [ -22.98, -12.96 ]
Pjevic 1999 15 63.1 (28.2) 15 60 (35.8) 13.2 % 3.10 [ -19.96, 26.16 ]
Sarantopoulos 1996 18 72 (37) 21 78 (41) 12.4 % -6.00 [ -30.49, 18.49 ]
Wordliczek 2002 30 86 (37) 30 100 (37) 16.3 % -14.00 [ -32.72, 4.72 ]
Total (95% CI) 140 158 100.0 % -8.15 [ -19.45, 3.14 ]
Heterogeneity: Tau2 = 112.29; Chi2 = 13.42, df = 5 (P = 0.02); I2 =63%
Test for overall effect: Z = 1.41 (P = 0.16)
Test for subgroup differences: Not applicable
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Analysis 1.6. Comparison 1 Preventive versus postincision opioids for postoperative pain, Outcome 6
Pruritus (long term).
Review: Pre-emptive and preventive opioids for postoperative pain in adults undergoing all types of surgery
Comparison: 1 Preventive versus postincision opioids for postoperative pain
Outcome: 6 Pruritus (long term)
Study or subgroup Preventive Post-incision Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Griffin 1997 3/18 2/16 14.9 % 1.33 [ 0.25, 7.00 ]
Sert 2012 0/25 0/25 Not estimable
Shen 2008 12/148 18/151 85.1 % 0.68 [ 0.34, 1.36 ]
Total (95% CI) 191 192 100.0 % 0.75 [ 0.40, 1.43 ]
Total events: 15 (Preventive), 20 (Post-incision)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.54, df = 1 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 0.87 (P = 0.38)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours preventive Favours post-incision
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Analysis 1.7. Comparison 1 Preventive versus postincision opioids for postoperative pain, Outcome 7
Bradycardia (incidence).
Review: Pre-emptive and preventive opioids for postoperative pain in adults undergoing all types of surgery
Comparison: 1 Preventive versus postincision opioids for postoperative pain
Outcome: 7 Bradycardia (incidence)
Study or subgroup Preventive Post-incision Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Mansfield 1994 0/31 1/31 100.0 % 0.33 [ 0.01, 7.88 ]
Sert 2012 0/25 0/25 Not estimable
Total (95% CI) 56 56 100.0 % 0.33 [ 0.01, 7.88 ]
Total events: 0 (Preventive), 1 (Post-incision)
Heterogeneity: not applicable
Test for overall effect: Z = 0.68 (P = 0.50)
Test for subgroup differences: Not applicable
0.002 0.1 1 10 500
Favours preventive Favours post-incision
Analysis 1.8. Comparison 1 Preventive versus postincision opioids for postoperative pain, Outcome 8
Bradycardia (mean dose of chronotrope in mcg).
Review: Pre-emptive and preventive opioids for postoperative pain in adults undergoing all types of surgery
Comparison: 1 Preventive versus postincision opioids for postoperative pain
Outcome: 8 Bradycardia (mean dose of chronotrope in mcg)
Study or subgroup Preventive Post-incision
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Mansfield 1994 31 0.001 (0.001) 31 9.68 (53.88) 100.0 % -9.68 [ -28.65, 9.29 ]
Sert 2012 25 0 (0) 25 0 (0) Not estimable
Total (95% CI) 56 56 100.0 % -9.68 [ -28.65, 9.29 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.00 (P = 0.32)
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours preventive Favours post-incision
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Analysis 1.9. Comparison 1 Preventive versus postincision opioids for postoperative pain, Outcome 9
Hypotension (incidence).
Review: Pre-emptive and preventive opioids for postoperative pain in adults undergoing all types of surgery
Comparison: 1 Preventive versus postincision opioids for postoperative pain
Outcome: 9 Hypotension (incidence)
Study or subgroup Preventive Post-incision Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Griffin 1997 3/19 2/19 78.1 % 1.50 [ 0.28, 7.99 ]
Sert 2012 0/25 1/25 21.9 % 0.33 [ 0.01, 7.81 ]
Total (95% CI) 44 44 100.0 % 1.08 [ 0.25, 4.73 ]
Total events: 3 (Preventive), 3 (Post-incision)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.69, df = 1 (P = 0.41); I2 =0.0%
Test for overall effect: Z = 0.10 (P = 0.92)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours preventive Favours post-incision
A D D I T I O N A L T A B L E S
Table 1. Morphine equivalent conversion factors
Opioid Conversion factor
Oral morphine 3:1
Pethidine/meperidine 10:1
Ketobemidone 1:1
Tramadol 20:1
Fentanyl 1:100
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Table 1. Morphine equivalent conversion factors (Continued)
Remifentanil 1:100
Piritramide 1:0.75
Intravenous hydromorphone 1:3
Oral hydrocodone 2:1
Intravenous oxycodone 1:1.5
Oral oxycodone 2.5:1
Papaveretum 1.5:1
Meptazinol 5:1
Nalbuphine 1:1
Propoxyphene 10:1
Sublingual buprenorphine 1:25
Trimeperidine 2:1
Table 2. Pre-emptive versus postincision opioids: other outcomes
Study Outcome Effect estimate Participants
Pozos-Guillen 2007 Early acute postoperative pain MD -1.20, 95% CI -1.75 to -0.65 40
Pozos-Guillen 2007 Late acute postoperative pain MD -2.10, 95% CI -2.57 to -1.63 40
CI: confidence interval
MD: mean difference
Table 3. Preventive versus postincision opioids: other outcomes
Study Outcome Effect estimate Participants
Sert 2012 Hypotension (mean dose of in-
otrope/vasopressor in mg)
MD -0.20, 95% CI -0.59 to 0.19 50
Kiliçkan 2001 Sedation (short term) MD 0.60, 95% CI -2.22 to 3.42 40
Kiliçkan 2001 Sedation (long term) MD 1.40, 95% CI -3.19 to 5.99 40
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Table 3. Preventive versus postincision opioids: other outcomes (Continued)
Shen 2008 Patient satisfaction (long term) MD -0.22, 95% CI -0.53 to 0.09 299
CI: confidence interval
MD: mean difference
A P P E N D I C E S
Appendix 1. MEDLINE search strategy
1. preemptive analgesia [ti.ab]
2. postoperative pain [ti.ab]
3. preventive analgesia [ti.ab]
4. preincision* [ti.ab]
5. exp PAIN, POSTOPERATIVE/
6. 1 OR 2 OR 3 OR 4 OR 5
7. opioid* or opiate* [ti.ab]
8. morphine OR diamorphine OR fentanyl OR remifentanil OR alfentanil OR meperidine OR pethidine OR tramadol OR ketobe-
midone [ti.ab]
9. 7 OR 8
10. 6 AND 9
11. randomi?ed controlled trial [pt]
12. controlled clinical trial [pt]
13. randomi?ed [ti.ab]
14. placebo [ti.ab]
15. drug therapy [sh]
17. randomly [ti.ab]
18. trial [ti.ab]
19. groups [ti.ab]
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20. 11 OR 12 OR 13 OR 14 OR 15 OR 16 OR 17 OR 18
21. 10 AND 20
22. 21 [Limit to: (Age group Young Adult or Adult or Middle aged or Aged or Aged, 80 and over) and Humans]
Appendix 2. Embase and CINAHL search strategy
1. preemptive [ti,ab]
2. preventive [ti,ab]
3. 1 OR 2
4. exp ’POSTOPERATIVE PAIN’/
5. surgery [ti,ab]
6. pain [ti,ab]
7. 4 OR 5 OR 6
8. 3 AND 7
9. opioid* OR opiate* [ti,ab]
10. morphine OR diamorphine OR fentanyl OR remifentanil OR alfentanil OR meperidine OR pethidine OR tramadol OR ketobe-
midone [ti,ab]
11. 9 OR 10
12. 8 AND 11
Appendix 3. AMED search strategy
1. preemptive [ti,ab]
2. preventive [ti,ab]
3. 1 OR 2
4. surgery [ti,ab]
5. pain [ti,ab]
6. 4 OR 5
7. 3 AND 6
8. opioid* OR opiate* [ti,ab]
9. morphine OR diamorphine OR fentanyl OR remifentanil OR alfentanil OR meperidine OR pethidine OR tramadol OR ketobe-
midone [ti,ab]
10. 8 OR 9
11. 7 AND 10
Appendix 4. ’Risk of bias’ tool
Random sequence generation
Selection bias (biased allocation to interventions) due to inadequate generation of a randomized sequence.
Criteria for a judgement of ’low risk’ of bias
The investigators describe a random component in the sequence generation process such as:
1. referring to a random number table;
2. using a computer random number generator;
3. coin tossing;
4. shuffling cards or envelopes;
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5. throwing dice;
6. drawing of lots;
7. minimization.*
*Minimization may be implemented without a random element and is considered to be the equivalent of random.
Criteria for a judgement of ’high risk’ of bias
The investigators describe a non-random component in the sequence generation process. Usually, the description would involve some
systematic, non-random approach, for example:
1. sequence generated by odd or even date of birth;
2. sequence generated by some rule based on date (or day) of admission;
3. sequence generated by some rule based on hospital or clinic record number.
Other non-random approaches occur much less frequently than the systematic approaches mentioned above and tend to be obvious.
They usually involve judgement or some method of non-random categorization of participants, for example:
1. allocation by judgement of the clinician;
2. allocation by preference of the participant;
3. allocation based on the results of a laboratory test or a series of tests;
4. allocation by availability of the intervention.
Criteria for a judgement of ’unclear risk’ of bias
Insufficient information about the sequence generation process to permit judgement of ’low risk’ or ’high risk’.
Allocation concealment
Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment.
Criteria for a judgement of ’low risk’ of bias
Participants and investigators enrolling participants could not foresee assignment because one of the following, or an equivalent method,
was used to conceal allocation:
1. central allocation (including telephone, web-based, and pharmacy-controlled randomization);
2. sequentially numbered drug containers of identical appearance;
3. sequentially numbered, opaque, sealed envelopes.
Criteria for a judgement of ’high risk’ of bias
Participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias, such as allocation
based on:
1. using an open random allocation schedule (e.g. a list of random numbers);
2. assignment envelopes used without appropriate safeguards (e.g. if envelopes were unsealed or nonopaque or not sequentially
numbered);
3. alternation or rotation;
4. date of birth;
5. case record number;
6. any other explicitly unconcealed procedure.
Criteria for a judgement of ’unclear risk’ of bias
Insufficient information to permit judgement of ’low risk’ or ’high risk’. This is usually the case if the method of concealment is not
described or not described in sufficient detail to allow a definitive judgement, for example if the use of assignment envelopes is described,
but it remains unclear whether envelopes were sequentially numbered, opaque, and sealed.
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Blinding of participants and personnel
Performance bias due to knowledge of the allocated interventions by participants and personnel during the study.
Criteria for a judgement of ’low risk’ of bias
Any one of the following:
1. no blinding or incomplete blinding, but the review authors judge that the outcome is not likely to be influenced by lack of
blinding;
2. blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken.
Criteria for a judgement of ’high risk’ of bias
Any one of the following:
1. no blinding or incomplete blinding, and the outcome is likely to be influenced by lack of blinding;
2. blinding of key study participants and personnel attempted, but likely that the blinding could have been broken, and the
outcome is likely to be influenced by lack of blinding.
Criteria for a judgement of ’unclear risk’ of bias
Any one of the following:
1. insufficient information to permit judgement of ’low risk’ or ’high risk’;
2. the study did not address this outcome.
Blinding of outcome assessment
Detection bias due to knowledge of the allocated interventions by outcome assessors.
Criteria for a judgement of ’low risk’ of bias
Any one of the following:
1. no blinding of outcome assessment, but the review authors judge that the outcome measurement is not likely to be influenced by
lack of blinding;
2. blinding of outcome assessment ensured, and unlikely that the blinding could have been broken.
Criteria for a judgement of ’high risk’ of bias
Any one of the following:
1. no blinding of outcome assessment, and the outcome measurement is likely to be influenced by lack of blinding;
2. blinding of outcome assessment, but likely that the blinding could have been broken, and the outcome measurement is likely to
be influenced by lack of blinding.
Criteria for a judgement of ’unclear risk’ of bias
Any one of the following:
1. insufficient information to permit judgement of ’low risk’ or ’high risk’;
2. the study did not address this outcome.
Incomplete outcome data
Attrition bias due to the amount, nature, or handling of incomplete outcome data.
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Criteria for a judgement of ’low risk’ of bias
Any one of the following:
1. no missing outcome data;
2. reasons for missing outcome data unlikely to be related to true outcome (for survival data, censoring unlikely to introduce bias);
3. missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups;
4. for dichotomous outcome data, the proportion of missing outcomes compared with observed event risk not enough to have a
clinically relevant impact on the intervention effect estimate;
5. for continuous outcome data, plausible effect size (difference in means or standardized difference in means) among missing
outcomes not enough to have a clinically relevant impact on observed effect size;
6. missing data have been imputed using appropriate methods.
Criteria for a judgement of ’high risk’ of bias
Any one of the following:
1. reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing
data across intervention groups;
2. for dichotomous outcome data, the proportion of missing outcomes compared with observed event risk enough to induce
clinically relevant bias in intervention effect estimate;
3. for continuous outcome data, plausible effect size (difference in means or standardized difference in means) among missing
outcomes enough to induce clinically relevant bias in observed effect size;
4. ’as-treated’ analysis done with substantial departure of the intervention received from that assigned at randomization;
5. potentially inappropriate application of simple imputation.
Criteria for a judgement of ’unclear risk’ of bias
Any one of the following:
1. insufficient reporting of attrition/exclusions to permit judgement of ’low risk’ or ’high risk’ (e.g. number randomized not stated,
no reasons for missing data provided);
2. the study did not address this outcome.
Selective reporting
Reporting bias due to selective outcome reporting.
Criteria for a judgement of ’low risk’ of bias
Any of the following:
1. the study protocol is available and all of the study’s prespecified (primary and secondary) outcomes that are of interest in the
review have been reported in the prespecified way;
2. the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that
were prespecified (convincing text of this nature may be uncommon).
Criteria for a judgement of ’high risk’ of bias
Any one of the following:
1. not all of the study’s prespecified primary outcomes have been reported;
2. one or more primary outcomes is reported using measurements, analysis methods, or subsets of the data (e.g. subscales) that were
not prespecified;
3. one or more reported primary outcomes were not prespecified (unless clear justification for their reporting is provided, such as
an unexpected adverse effect);
4. one or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta-analysis;
5. the study report fails to include results for a key outcome that would be expected to have been reported for such a study.
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Criteria for a judgement of ’unclear risk’ of bias
Insufficient information to permit judgement of ’low risk’ or ’high risk’. It is likely that the majority of studies will fall into this category.
Other bias
Bias due to problems not covered elsewhere in the table.
Criteria for a judgement of ’low risk’ of bias
The study appears to be free of other sources of bias.
Criteria for a judgement of ’high risk’ of bias
There is at least one important risk of bias. For example, the study:
1. had a potential source of bias related to the specific study design used;
2. has been claimed to have been fraudulent; or
3. had some other problem.
Criteria for a judgement of ’unclear risk’ of bias
There may be a risk of bias, but there is either:
1. insufficient information to assess whether an important risk of bias exists; or
2. insufficient rationale or evidence that an identified problem will introduce bias.
Appendix 5. Data extraction form
Review title or ID
Study ID (surname of first author and year first full report of study was published e.g. Smith 2001)
Report IDs of other reports of this study (e.g. duplicate publications, follow-up studies)
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Notes:
1. General information
Date form completed (dd/mm/yyyy)
Name/ID of person extracting data
Report title
(title of paper/abstract/report that data are extracted from)
Report ID
(ID for this paper/abstract/report)
Reference details
Report author contact details
Publication type
(e.g. full report, abstract, letter)
Study funding sources
(including role of funders)
Possible conflicts of interest
(for study authors)
Notes:
2. Study eligibility
Study
characteristics
Eligibility criteria
(Insert eligibility criteria for each
characteristic as defined in the
Protocol)
Yes No Unclear Location in text
(pg & ¶/fig/table)
Type of study Randomized controlled trial
Controlled clinical trial
(quasi-randomized trial)
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(Continued)
Participants
Types of inter-
vention
Types of out-
come measures
INCLUDE EXCLUDE
Reason for ex-
clusion
Notes:
DO NOT PROCEED IF STUDY EXCLUDED FROM REVIEW
3. Population and setting
Description
Include comparative information for
each group (i.e. intervention and con-
trols) if available
Location in text
(pg & ¶/fig/table)
Population description
(from which study participants
are drawn)
Setting
(including location and social
context)
Inclusion criteria
Exclusion criteria
Method/s of recruitment of
participants
Informed consent obtained Yes No Unclear
Notes:
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4. Methods
Descriptions as stated in report/
paper
Location in text
(pg & ¶/fig/table)
Aim of study
Design (e.g. parallel, cross-over,
cluster)
Unit of allocation
(by individuals, cluster/groups or
body parts)
Start date
End date
Total study duration
Ethical approval needed/ob-
tained for study
Yes No Unclear
Notes:
5. ’Risk of bias’ assessment
See Chapter 8 of the Cochrane Handbook
Domain Risk of bias Support for judgement Location in text
(pg & ¶/fig/table)
Low risk High risk Unclear
Random sequence
generation
(selection bias)
Allocation
concealment
(selection bias)
Blinding of partic-
ipants and person-
nel
(performance bias)
Outcome group: All/
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(Continued)
(if required) Outcome group:
Blinding of out-
come assessment
(detection bias)
Outcome group: All/
(if required) Outcome group:
Incomplete
outcome data
(attrition bias)
Selective outcome
reporting?
(reporting bias)
Other bias
Notes:
6. Participants
Provide overall data and, if available, comparative data for each intervention or comparison group.
Description as stated in report/paper Location in text
(pg & ¶/fig/table)
Total no. randomized
Baseline imbalances
Withdrawals and exclusions
(if not provided below by outcome)
Age
Sex
Other treatment received (additional to
study intervention)
Subgroups measured
Subgroups reported
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(Continued)
Notes:
7. Intervention groups
Copy and paste table for each intervention and comparison group
Intervention Group 1
Description as stated in report/paper Location in text
(pg & ¶/fig/table)
Group name
No. randomized to group
Description (include sufficient detail for
replication, e.g. content, dose, components)
Duration of treatment period
Timing (e.g. how long before surgery?)
Delivery (e.g. intravenous, oral or intra-
muscular)
Co-interventions
Notes:
8. Outcomes
Copy and paste table for each outcome.
Outcome 1
Description as stated in report/
paper
Location in text
(pg & ¶/fig/table)
Outcome name
Time points measured
Time points reported
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(Continued)
Outcome definition (with di-
agnostic criteria if relevant)
Person measuring/reporting
Unit of measurement
(if relevant)
Is outcome/tool validated? Yes No Unclear
Notes:
9. Results
Copy and paste the appropriate table for each outcome, including additional tables for each time point and subgroup as required.
Dichotomous outcome
Description as stated in report/paper Location in text
(pg & ¶/fig/table)
Comparison
Outcome
Subgroup
Time point
(specify whether
from start or end
of intervention)
Results Intervention Comparison
No. events No. participants No. events No. participants
No. miss-
ing participants
and reasons
No. par-
ticipants moved
from
other group and
reasons
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(Continued)
Any other re-
sults reported
Reanalysis re-
quired? (specify)
Yes No Unclear
Reanalysis pos-
sible?
Yes No Unclear
Reanalysed re-
sults
Notes:
Continuous outcome
Description as stated in report/paper Location in text
(pg & ¶/fig/table)
Comparison
Outcome
Subgroup
Time point
(specify whether from
start or end of inter-
vention)
Post-interven-
tion or change from
baseline?
Results Intervention Comparison
Mean SD
(or other
variance)
No.
participants
Mean SD (or
other vari-
ance)
No. partici-
pants
No. missing partic-
ipants and reasons
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(Continued)
No. participants
moved from other
group and reasons
Any other results
reported
Reanalysis
required? (specify)
Yes No Unclear
Reanalysis
possible?
Yes No Unclear
Reanalysed results
Notes:
10. Applicability
Have important populations been excluded from the study?
(consider disadvantaged populations, and possible differences in the
intervention effect)
Yes No Unclear
Is the intervention likely to be aimed at disadvantaged groups?
(e.g. lower socioeconomic groups)
Yes No Unclear
Does the study directly address the review question?
(any issues of partial or indirect applicability)
Yes No Unclear
Notes:
11. Other information
Description as stated in report/paper Location in text
(pg & ¶/fig/table)
Key conclusions of study authors
References to other relevant studies
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(Continued)
Correspondence required for further
study information (from whom, what and
when)
Notes:
C O N T R I B U T I O N S O F A U T H O R S
Brett Doleman (BD), Jo Leonardi-Bee (JLB), Thomas Heinink (TH), Debamita Bhattacharjee (DB), Jon Lund (JL), John P Williams
(JPW).
Conceiving the review: BD, JPW
Co-ordinating the review: BD, JPW, JL, JLB, TH, DB
Undertaking manual searches: BD
Screening search results: BD
Organizing retrieval of papers: BD
Screening retrieved papers against inclusion criteria: BD, JPW, TH
Appraising the quality of papers: BD, JPW, TH, JLB
Abstracting data from papers: BD, JPW, TH
Writing to authors of papers for additional information: BD
Providing additional data about papers: BD
Obtaining and screening data on unpublished studies: BD
Data management for the review: BD, JPW, DB, JL
Entering data into Review Manager 5: BD, JPW
Review Manager 5 statistical data: BD, JPW
Other statistical analysis not using Review Manager 5: BD
Interpretation of data: BD, JPW, JLB
Statistical inferences: BD, JPW, JLB
Writing the review: BD, JPW, JLB, TH
Securing funding for the review: N/A
Performing previous work that was the foundation of the present study: BD, JPW, JL, TH
Guarantor for the review (one author): BD
Person responsible for reading and checking review before submission: BD, JL, JPW, JLB, TH, DB
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D E C L A R A T I O N S O F I N T E R E S T
Brett Doleman: received a grant in 2015 from the Association of Anaesthetists of Great Britain and Ireland (AAGBI) (free from
industry support) for a randomized controlled trial of preventive paracetamol and has previously undertakenmeta-analyses of preventive
paracetamol and gabapentin (Doleman 2015a; Doleman 2015b).
Jo Leonardi-Bee: no declarations of interest.
Thomas Heinink: no declarations of interest.
Debamita Bhattacharjee: no declarations of interest.
Jon Lund: received a grant in 2015 fromAAGBI (free from industry support) for a randomized controlled trial of preventive paracetamol
and has previously undertaken meta-analyses of preventive paracetamol and gabapentin (Doleman 2015a; Doleman 2015b).
John P Williams: received a grant in 2015 from AAGBI (free from industry support) for a randomized controlled trial of preventive
paracetamol and has previously undertaken meta-analyses of preventive paracetamol and gabapentin (Doleman 2015a; Doleman
2015b).
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We made the following changes from the published protocol (Doleman 2017b).
1. We changed the title to more accurately reflect the content of the review.
2. We added a new author (DB) to assist with data collection.
3. We only reported number needed to treat for an additional beneficial/harmful outcome (NNTB/NNTH) if we found significant
differences on analysis, as this information would not add further information to the already reported effect estimates.
4. We changed the outcomes reported in the ’Summary of findings’ tables so as to not exceed the maximum recommended. We
included our primary outcomes and adverse events as well as outcomes of importance for analgesic trials, and removed nausea and
vomiting, time to analgesic request, and chronic pain.
5. We removed the specific measurement scale ’Ramsey sedation scale’ from the sedation outcome to be more inclusive.
6. Following advice from the review statistician, we changed some language in the Data synthesis section regarding inputting data
for continuous outcomes.
7. We added information on specific opioid agents that were assigned to each subgroup category for clarity (see Subgroup analysis
and investigation of heterogeneity).
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